1	1	Immunization	immunization	NN	2	nsubj	0	12	_	_
1	2	prevents	prevent	VBZ	0	ROOT	13	21	_	_
1	3	illness	illness	NN	2	dobj	22	29	_	_
1	4	,	,	,	3	punct	29	30	_	_
1	5	disability	disability	NN	3	conj	31	41	_	_
1	6	and	and	CC	3	cc	42	45	_	_
1	7	death	death	NN	3	conj	46	51	_	_
1	8	from	from	IN	10	case	52	56	_	_
1	9	vaccine-preventable	vaccine-preventable	JJ	10	amod	57	76	_	_
1	10	diseases	disease	NNS	2	nmod	77	85	_	_
1	11	including	include	VBG	13	case	86	95	_	_
1	12	cervical	cervical	JJ	13	amod	96	104	_	_
1	13	cancer	cancer	NN	10	nmod	105	111	_	_
1	14	,	,	,	13	punct	111	112	_	_
1	15	diphtheria	diphtheria	NN	13	conj	113	123	_	_
1	16	,	,	,	13	punct	123	124	_	_
1	17	hepatitis	hepatitis	NN	18	compound	125	134	_	_
1	18	B	b	NN	13	conj	135	136	_	_
1	19	,	,	,	13	punct	136	137	_	_
1	20	measles	measles	NNS	13	conj	138	145	_	_
1	21	,	,	,	13	punct	145	146	_	_
1	22	mumps	mumps	NNS	13	conj	147	152	_	_
1	23	,	,	,	13	punct	152	153	_	_
1	24	pertussis	pertussis	NN	25	compound	154	163	_	_
1	25	(	(	NN	13	conj	164	165	_	_
1	26	whooping	whooping	JJ	28	amod	165	173	_	_
1	27	cough	cough	NN	28	compound	174	179	_	_
1	28	)	)	NN	25	dep	179	180	_	_
1	29	,	,	,	13	punct	180	181	_	_
1	30	pneumonia	pneumonia	NN	13	conj	182	191	_	_
1	31	,	,	,	13	punct	191	192	_	_
1	32	polio	polio	NNP	13	conj	193	198	_	_
1	33	,	,	,	13	punct	198	199	_	_
1	34	rotavirus	rotavirus	NN	35	compound	200	209	_	_
1	35	diarrhoea	diarrhoea	NN	13	conj	210	219	_	_
1	36	,	,	,	13	punct	219	220	_	_
1	37	rubella	rubella	NN	13	conj	221	228	_	_
1	38	and	and	CC	13	cc	229	232	_	_
1	39	tetanus	tetanus	NN	13	conj	233	240	_	_
1	40	.	.	.	2	punct	240	241	_	_

2	1	Global	global	JJ	3	amod	242	248	_	_
2	2	vaccination	vaccination	NN	3	compound	249	260	_	_
2	3	coverage	coverage	NN	6	nsubj	261	269	_	_
2	4	is	be	VBZ	6	aux	270	272	_	_
2	5	generally	generally	RB	6	advmod	273	282	_	_
2	6	holding	hold	VBG	0	ROOT	283	290	_	_
2	7	steady	steady	JJ	6	xcomp	291	297	_	_
2	8	.	.	.	6	punct	297	298	_	_

3	1	Uptake	uptake	NN	8	nsubj	299	305	_	_
3	2	of	of	IN	6	case	306	308	_	_
3	3	new	new	JJ	6	amod	309	312	_	_
3	4	and	and	CC	3	cc	313	316	_	_
3	5	underused	underused	JJ	3	conj	317	326	_	_
3	6	vaccines	vaccine	NNS	1	nmod	327	335	_	_
3	7	is	be	VBZ	8	aux	336	338	_	_
3	8	increasing	increase	VBG	0	ROOT	339	349	_	_
3	9	.	.	.	8	punct	349	350	_	_

4	1	Immunization	immunization	NN	3	nsubj	351	363	_	_
4	2	currently	currently	RB	3	advmod	364	373	_	_
4	3	averts	avert	VBZ	0	ROOT	374	380	_	_
4	4	an	a	DT	6	det	381	383	_	_
4	5	estimated	estimate	VBN	6	amod	384	393	_	_
4	6	2	2	CD	3	dobj	394	395	B-persongroup-8037	_
4	7	to	to	TO	10	case	396	398	I-persongroup-8037	_
4	8	3	3	CD	9	compound	399	400	I-persongroup-8037	_
4	9	million	million	CD	10	nummod	401	408	I-persongroup-8037	_
4	10	deaths	death	NNS	6	nmod	409	415	I-persongroup-8037	_
4	11	every	every	DT	12	det	416	421	_	_
4	12	year	year	NN	10	dep	422	426	_	_
4	13	.	.	.	3	punct	426	427	_	_

5	1	An	a	DT	5	det	428	430	_	_
5	2	additional	additional	JJ	4	advmod	431	441	_	_
5	3	1.5	1.5	CD	4	compound	442	445	B-persongroup-8038	_
5	4	million	million	CD	5	nummod	446	453	I-persongroup-8038	_
5	5	deaths	death	NNS	8	nsubjpass	454	460	I-persongroup-8038	_
5	6	could	could	MD	8	aux	461	466	_	_
5	7	be	be	VB	8	auxpass	467	469	_	_
5	8	avoided	avoid	VBN	0	ROOT	470	477	_	_
5	9	,	,	,	8	punct	477	478	_	_
5	10	however	however	RB	8	advmod	479	486	_	_
5	11	,	,	,	8	punct	486	487	_	_
5	12	if	if	IN	16	mark	488	490	_	_
5	13	global	global	JJ	15	amod	491	497	_	_
5	14	vaccination	vaccination	NN	15	compound	498	509	_	_
5	15	coverage	coverage	NN	16	nsubj	510	518	_	_
5	16	improves	improve	VBZ	8	advcl	519	527	_	_
5	17	.	.	.	8	punct	527	528	_	_

6	1	An	a	DT	5	det	529	531	_	_
6	2	estimated	estimate	VBN	5	amod	532	541	_	_
6	3	19.4	19.4	CD	4	compound	542	546	B-persongroup-8039	_
6	4	million	million	CD	5	nummod	547	554	I-persongroup-8039	_
6	5	infants	infant	NNS	9	nsubj	555	562	I-persongroup-8039	_
6	6	worldwide	worldwide	RB	9	advmod	563	572	I-persongroup-8039	_
6	7	are	be	VBP	9	aux	573	576	_	_
6	8	still	still	RB	9	advmod	577	582	_	_
6	9	missing	miss	VBG	0	ROOT	583	590	_	_
6	10	out	out	RP	9	compound:prt	591	594	_	_
6	11	on	on	IN	13	case	595	597	_	_
6	12	basic	basic	JJ	13	amod	598	603	_	_
6	13	vaccines	vaccine	NNS	9	nmod	604	612	_	_
6	14	.	.	.	9	punct	612	613	_	_

7	1	Immunization	immunization	NN	2	nsubj	624	636	_	_
7	2	averts	avert	VBZ	0	ROOT	637	643	_	_
7	3	an	a	DT	9	det	644	646	_	_
7	4	estimated	estimate	VBN	9	amod	647	656	_	_
7	5	2	2	CD	8	compound	657	658	B-persongroup-8040	_
7	6	to	to	TO	8	dep	659	661	I-persongroup-8040	_
7	7	3	3	CD	8	compound	662	663	I-persongroup-8040	_
7	8	million	million	CD	9	nummod	664	671	I-persongroup-8040	_
7	9	deaths	death	NNS	2	dobj	672	678	I-persongroup-8040	_
7	10	every	every	DT	11	det	679	684	_	_
7	11	year	year	NN	9	dep	685	689	_	_
7	12	from	from	IN	13	case	690	694	_	_
7	13	diphtheria	diphtheria	NN	9	nmod	695	705	_	_
7	14	,	,	,	13	punct	705	706	_	_
7	15	tetanus	tetanus	NN	13	conj	707	714	_	_
7	16	,	,	,	13	punct	714	715	_	_
7	17	pertussis	pertussis	NN	18	compound	716	725	_	_
7	18	(	(	NN	13	conj	726	727	_	_
7	19	whooping	whooping	JJ	21	amod	727	735	_	_
7	20	cough	cough	NN	21	compound	736	741	_	_
7	21	)	)	NN	18	dep	741	742	_	_
7	22	,	,	,	13	punct	742	743	_	_
7	23	and	and	CC	13	cc	744	747	_	_
7	24	measles	measles	NNS	13	conj	748	755	_	_
7	25	;	;	:	2	punct	755	756	_	_
7	26	however	however	RB	35	advmod	757	764	_	_
7	27	,	,	,	35	punct	764	765	_	_
7	28	an	a	DT	31	advmod	766	768	_	_
7	29	additional	additional	JJ	31	advmod	769	779	_	_
7	30	1.5	1.5	CD	31	compound	780	783	B-persongroup-8041	_
7	31	million	million	CD	32	nummod	784	791	I-persongroup-8041	_
7	32	deaths	death	NNS	35	nsubjpass	792	798	I-persongroup-8041	_
7	33	could	could	MD	35	aux	799	804	_	_
7	34	be	be	VB	35	auxpass	805	807	_	_
7	35	avoided	avoid	VBN	2	parataxis	808	815	_	_
7	36	if	if	IN	40	mark	816	818	_	_
7	37	global	global	JJ	39	amod	819	825	_	_
7	38	vaccination	vaccination	NN	39	compound	826	837	_	_
7	39	coverage	coverage	NN	40	nsubj	838	846	_	_
7	40	improves	improve	VBZ	35	advcl	847	855	_	_
7	41	.	.	.	2	punct	855	856	_	_

8	1	Global	global	JJ	3	amod	857	863	_	_
8	2	vaccination	vaccination	NN	3	compound	864	875	_	_
8	3	coverage	coverage	NN	4	nsubj	876	884	_	_
8	4	–	–	VBD	0	ROOT	885	886	_	_
8	5	the	the	DT	6	det	887	890	_	_
8	6	proportion	proportion	NN	18	nsubj	891	901	_	_
8	7	of	of	IN	11	case	902	904	_	_
8	8	the	the	DT	9	det	905	908	B-persongroup-8043	_
8	9	world	world	NN	11	nmod:poss	909	914	I-persongroup-8043	_
8	10	’s	’s	POS	9	case	914	916	I-persongroup-8043	_
8	11	children	child	NNS	6	nmod	917	925	B-persongroup-8042	_
8	12	who	who	WP	13	nsubj	926	929	I-persongroup-8042	_
8	13	receive	receive	VBP	11	ccomp	930	937	I-persongroup-8042	_
8	14	recommended	recommend	VBN	15	amod	938	949	I-persongroup-8042	_
8	15	vaccines	vaccine	NNS	16	nsubj	950	958	I-persongroup-8042	_
8	16	–	–	VBP	13	ccomp	959	960	_	_
8	17	has	have	VBZ	18	aux	961	964	_	_
8	18	remained	remain	VBN	4	ccomp	965	973	_	_
8	19	steady	steady	JJ	18	xcomp	974	980	_	_
8	20	for	for	IN	24	case	981	984	_	_
8	21	the	the	DT	24	det	985	988	_	_
8	22	past	past	JJ	24	amod	989	993	_	_
8	23	few	few	JJ	24	amod	994	997	_	_
8	24	years	year	NNS	18	nmod	998	1003	_	_
8	25	.	.	.	4	punct	1003	1004	_	_

9	1	During	during	IN	2	case	1015	1021	_	_
9	2	2015	2015	CD	14	nmod	1022	1026	_	_
9	3	,	,	,	14	punct	1026	1027	_	_
9	4	about	about	IN	6	case	1028	1033	B-persongroup-8044	_
9	5	86	86	CD	6	nummod	1034	1036	I-persongroup-8044	_
9	6	%	%	NN	7	advmod	1036	1037	I-persongroup-8044	_
9	7	(	(	CD	14	nsubj	1038	1039	I-persongroup-8044	_
9	8	116	116	CD	9	compound	1039	1042	I-persongroup-8044	_
9	9	million	million	CD	10	nummod	1043	1050	I-persongroup-8044	_
9	10	)	)	NN	7	nmod	1050	1051	I-persongroup-8044	_
9	11	of	of	IN	10	case	1052	1054	I-persongroup-8044	_
9	12	infants	infant	NNS	10	dep	1055	1062	I-persongroup-8044	_
9	13	worldwide	worldwide	JJ	12	amod	1063	1072	I-persongroup-8044	_
9	14	received	receive	VBN	0	ROOT	1073	1081	_	_
9	15	3	3	CD	16	nummod	1082	1083	_	_
9	16	doses	dose	NNS	14	dobj	1084	1089	_	_
9	17	of	of	IN	22	case	1090	1092	_	_
9	18	diphtheria-tetanus-pertussis	diphtheria-tetanus-pertussis	NN	22	compound	1093	1121	_	_
9	19	(	(	CD	22	nummod	1122	1123	_	_
9	20	DTP3	dtp3	NN	22	compound	1123	1127	_	_
9	21	)	)	NN	22	compound	1127	1128	_	_
9	22	vaccine	vaccine	NN	16	nmod	1129	1136	_	_
9	23	,	,	,	14	punct	1136	1137	_	_
9	24	protecting	protect	VBG	14	advcl	1138	1148	_	_
9	25	them	they	PRP	24	dobj	1149	1153	B-persongroup-8045	_
9	26	against	against	IN	28	case	1154	1161	_	_
9	27	infectious	infectious	JJ	28	amod	1162	1172	_	_
9	28	diseases	disease	NNS	24	nmod	1173	1181	_	_
9	29	that	that	WDT	31	nsubj	1182	1186	_	_
9	30	can	can	MD	31	aux	1187	1190	_	_
9	31	cause	cause	VB	28	acl:relcl	1191	1196	_	_
9	32	serious	serious	JJ	33	amod	1197	1204	_	_
9	33	illness	illness	NN	31	dobj	1205	1212	_	_
9	34	and	and	CC	33	cc	1213	1216	_	_
9	35	disability	disability	NN	33	conj	1217	1227	_	_
9	36	or	or	CC	31	cc	1228	1230	_	_
9	37	be	be	VB	38	cop	1231	1233	_	_
9	38	fatal	fatal	JJ	31	conj	1234	1239	_	_
9	39	.	.	.	14	punct	1239	1240	_	_

10	1	By	by	IN	2	case	1241	1243	_	_
10	2	2015	2015	CD	7	nmod	1244	1248	_	_
10	3	,	,	,	7	punct	1248	1249	_	_
10	4	126	126	CD	5	nummod	1250	1253	B-persongroup-8046	_
10	5	countries	country	NNS	7	nsubj	1254	1263	I-persongroup-8046	_
10	6	had	have	VBD	7	aux	1264	1267	_	_
10	7	reached	reach	VBN	0	ROOT	1268	1275	_	_
10	8	at	at	IN	9	case	1276	1278	_	_
10	9	least	least	JJS	11	nmod:npmod	1279	1284	_	_
10	10	90	90	CD	11	compound	1285	1287	B-persongroup-8047	_
10	11	%	%	NN	12	nummod	1287	1288	I-persongroup-8047	_
10	12	coverage	coverage	NN	7	dobj	1289	1297	I-persongroup-8047	_
10	13	of	of	IN	15	case	1298	1300	_	_
10	14	DTP3	dtp3	NN	15	compound	1301	1305	_	_
10	15	vaccine	vaccine	NN	12	nmod	1306	1313	_	_
10	16	.	.	.	7	punct	1313	1314	_	_

11	1	Haemophilus	haemophilus	JJ	4	amod	1325	1336	_	_
11	2	influenzae	influenzae	NN	4	compound	1337	1347	_	_
11	3	type	type	NN	4	compound	1348	1352	_	_
11	4	b	b	NN	8	nsubj	1353	1354	_	_
11	5	(	(	CD	6	nummod	1355	1356	_	_
11	6	Hib	hib	NN	4	dep	1356	1359	_	_
11	7	)	)	CD	4	dep	1359	1360	_	_
11	8	causes	cause	VBZ	0	ROOT	1361	1367	_	_
11	9	meningitis	meningitis	NN	8	dobj	1368	1378	_	_
11	10	and	and	CC	9	cc	1379	1382	_	_
11	11	pneumonia	pneumonia	NN	9	conj	1383	1392	_	_
11	12	.	.	.	8	punct	1392	1393	_	_

12	1	Hib	hib	NN	2	compound	1394	1397	_	_
12	2	vaccine	vaccine	NN	5	nsubjpass	1398	1405	_	_
12	3	had	have	VBD	5	aux	1406	1409	_	_
12	4	been	be	VBN	5	auxpass	1410	1414	_	_
12	5	introduced	introduce	VBN	0	ROOT	1415	1425	_	_
12	6	in	in	IN	8	case	1426	1428	_	_
12	7	191	191	CD	8	nummod	1429	1432	B-persongroup-8048	_
12	8	countries	country	NNS	5	nmod	1433	1442	I-persongroup-8048	_
12	9	by	by	IN	11	case	1443	1445	_	_
12	10	the	the	DT	11	det	1446	1449	_	_
12	11	end	end	NN	5	nmod	1450	1453	_	_
12	12	of	of	IN	13	case	1454	1456	_	_
12	13	2015	2015	CD	11	nmod	1457	1461	_	_
12	14	.	.	.	5	punct	1461	1462	_	_

13	1	Global	global	JJ	2	amod	1463	1469	_	_
13	2	coverage	coverage	NN	10	nsubjpass	1470	1478	_	_
13	3	with	with	IN	5	case	1479	1483	_	_
13	4	3	3	CD	5	nummod	1484	1485	_	_
13	5	doses	dose	NNS	2	nmod	1486	1491	_	_
13	6	of	of	IN	8	case	1492	1494	_	_
13	7	Hib	hib	NN	8	compound	1495	1498	_	_
13	8	vaccine	vaccine	NN	5	nmod	1499	1506	_	_
13	9	is	be	VBZ	10	auxpass	1507	1509	_	_
13	10	estimated	estimate	VBN	0	ROOT	1510	1519	_	_
13	11	at	at	IN	13	case	1520	1522	_	_
13	12	64	64	CD	13	nummod	1524	1526	B-persongroup-8049	_
13	13	%	%	NN	10	nmod	1526	1527	I-persongroup-8049	_
13	14	.	.	.	10	punct	1527	1528	I-persongroup-8049	_

14	1	There	there	EX	2	expl	1529	1534	_	_
14	2	is	be	VBZ	0	ROOT	1535	1537	_	_
14	3	great	great	JJ	4	amod	1538	1543	_	_
14	4	variation	variation	NN	2	nsubj	1544	1553	_	_
14	5	between	between	IN	6	case	1554	1561	_	_
14	6	regions	region	NNS	4	nmod	1562	1569	B-persongroup-8050	_
14	7	.	.	.	2	punct	1569	1570	I-persongroup-8050	_

15	1	In	in	IN	3	case	1571	1573	_	_
15	2	the	the	DT	3	det	1574	1577	B-persongroup-8051	_
15	3	Americas	Americas	NNPS	7	nmod	1578	1586	I-persongroup-8051	_
15	4	,	,	,	7	punct	1586	1587	I-persongroup-8051	_
15	5	coverage	coverage	NN	7	nsubjpass	1588	1596	_	_
15	6	is	be	VBZ	7	auxpass	1597	1599	_	_
15	7	estimated	estimate	VBN	0	ROOT	1600	1609	_	_
15	8	at	at	IN	10	case	1610	1612	_	_
15	9	90	90	CD	10	nummod	1613	1615	B-persongroup-8052	_
15	10	%	%	NN	7	nmod	1615	1616	I-persongroup-8052	_
15	11	,	,	,	7	punct	1616	1617	I-persongroup-8052	_
15	12	while	while	IN	17	mark	1618	1623	_	_
15	13	it	it	PRP	17	nsubj	1624	1626	_	_
15	14	is	be	VBZ	17	cop	1627	1629	_	_
15	15	only	only	RB	17	advmod	1630	1634	_	_
15	16	25	25	CD	17	nummod	1636	1638	B-persongroup-8053	_
15	17	%	%	NN	7	advcl	1638	1639	I-persongroup-8053	_
15	18	and	and	CC	17	cc	1640	1643	_	_
15	19	56	56	CD	20	nummod	1645	1647	B-persongroup-8054	_
15	20	%	%	NN	17	conj	1647	1648	I-persongroup-8054	_
15	21	in	in	IN	24	case	1649	1651	_	_
15	22	the	the	DT	24	det	1652	1655	B-persongroup-8055	_
15	23	Western	Western	NNP	24	compound	1656	1663	I-persongroup-8055	_
15	24	Pacific	Pacific	NNP	17	nmod	1664	1671	I-persongroup-8055	_
15	25	and	and	CC	24	cc	1672	1675	_	_
15	26	South-East	South-East	NNP	28	compound	1676	1686	B-persongroup-8056	_
15	27	Asia	Asia	NNP	28	compound	1687	1691	I-persongroup-8056	_
15	28	Regions	Regions	NNPS	24	conj	1692	1699	I-persongroup-8056	_
15	29	respectively	respectively	RB	17	advmod	1700	1712	_	_
15	30	.	.	.	7	punct	1712	1713	_	_

16	1	Hepatitis	Hepatitis	NNP	2	compound	1724	1733	_	_
16	2	B	B	NNP	6	nsubj	1734	1735	_	_
16	3	is	be	VBZ	6	cop	1736	1738	_	_
16	4	a	a	DT	6	det	1739	1740	_	_
16	5	viral	viral	JJ	6	amod	1741	1746	_	_
16	6	infection	infection	NN	0	ROOT	1747	1756	_	_
16	7	that	that	WDT	8	nsubj	1757	1761	_	_
16	8	attacks	attack	VBZ	6	acl:relcl	1762	1769	_	_
16	9	the	the	DT	10	det	1770	1773	_	_
16	10	liver	liver	NN	8	dobj	1774	1779	_	_
16	11	.	.	.	6	punct	1779	1780	_	_

17	1	Hepatitis	Hepatitis	NNP	3	compound	1781	1790	_	_
17	2	B	B	NNP	3	compound	1791	1792	_	_
17	3	vaccine	vaccine	NN	8	nsubjpass	1793	1800	_	_
17	4	for	for	IN	5	case	1801	1804	_	_
17	5	infants	infant	NNS	3	nmod	1805	1812	B-persongroup-8057	_
17	6	had	have	VBD	8	aux	1813	1816	_	_
17	7	been	be	VBN	8	auxpass	1817	1821	_	_
17	8	introduced	introduce	VBN	0	ROOT	1822	1832	_	_
17	9	nationwide	nationwide	JJ	8	advmod	1833	1843	_	_
17	10	in	in	IN	12	case	1844	1846	_	_
17	11	185	185	CD	12	nummod	1847	1850	B-persongroup-8058	_
17	12	countries	country	NNS	9	nmod	1851	1860	I-persongroup-8058	_
17	13	by	by	IN	15	case	1861	1863	_	_
17	14	the	the	DT	15	det	1864	1867	_	_
17	15	end	end	NN	8	nmod	1868	1871	_	_
17	16	of	of	IN	17	case	1872	1874	_	_
17	17	2015	2015	CD	15	nmod	1875	1879	_	_
17	18	.	.	.	8	punct	1879	1880	_	_

18	1	Global	global	JJ	2	amod	1881	1887	_	_
18	2	coverage	coverage	NN	11	nsubjpass	1888	1896	_	_
18	3	with	with	IN	5	case	1897	1901	_	_
18	4	3	3	CD	5	nummod	1902	1903	_	_
18	5	doses	dose	NNS	2	nmod	1904	1909	_	_
18	6	of	of	IN	9	case	1910	1912	_	_
18	7	hepatitis	hepatitis	NN	9	compound	1913	1922	_	_
18	8	B	b	NN	9	compound	1923	1924	_	_
18	9	vaccine	vaccine	NN	5	nmod	1925	1932	_	_
18	10	is	be	VBZ	11	auxpass	1933	1935	_	_
18	11	estimated	estimate	VBN	0	ROOT	1936	1945	_	_
18	12	at	at	IN	14	case	1946	1948	_	_
18	13	83	83	CD	14	nummod	1950	1952	B-persongroup-8059	_
18	14	%	%	NN	11	nmod	1952	1953	I-persongroup-8059	_
18	15	and	and	CC	11	cc	1954	1957	_	_
18	16	is	be	VBZ	18	cop	1958	1960	_	_
18	17	as	as	RB	18	advmod	1961	1963	_	_
18	18	high	high	JJ	11	conj	1964	1968	_	_
18	19	as	as	IN	21	case	1969	1971	_	_
18	20	90	90	CD	21	nummod	1973	1975	B-persongroup-8060	_
18	21	%	%	NN	18	nmod	1975	1976	I-persongroup-8060	_
18	22	in	in	IN	25	case	1977	1979	_	_
18	23	the	the	DT	25	det	1980	1983	B-persongroup-8061	_
18	24	Western	Western	NNP	25	compound	1984	1991	I-persongroup-8061	_
18	25	Pacific	Pacific	NNP	21	nmod	1992	1999	I-persongroup-8061	_
18	26	.	.	.	11	punct	1999	2000	I-persongroup-8061	_

19	1	In	in	IN	2	case	2001	2003	_	_
19	2	addition	addition	NN	6	nmod	2004	2012	_	_
19	3	,	,	,	6	punct	2012	2013	_	_
19	4	96	96	CD	5	nummod	2014	2016	B-persongroup-8062	_
19	5	countries	country	NNS	6	nsubj	2017	2026	I-persongroup-8062	_
19	6	introduced	introduce	VBD	0	ROOT	2027	2037	_	_
19	7	one	one	CD	8	nummod	2038	2041	_	_
19	8	dose	dose	NN	6	dobj	2042	2046	_	_
19	9	of	of	IN	12	case	2047	2049	_	_
19	10	hepatitis	hepatitis	NN	12	compound	2050	2059	_	_
19	11	B	b	NN	12	compound	2060	2061	_	_
19	12	vaccine	vaccine	NN	8	nmod	2062	2069	_	_
19	13	to	to	TO	14	case	2070	2072	_	_
19	14	newborns	newborn	NNS	6	nmod	2073	2081	B-persongroup-8063	_
19	15	within	within	IN	19	case	2082	2088	_	_
19	16	the	the	DT	19	det	2089	2092	_	_
19	17	first	first	JJ	19	amod	2093	2098	_	_
19	18	24	24	CD	19	nummod	2099	2101	_	_
19	19	hours	hour	NNS	6	nmod	2102	2107	_	_
19	20	of	of	IN	21	case	2108	2110	_	_
19	21	life	life	NN	19	nmod	2111	2115	_	_
19	22	,	,	,	6	punct	2115	2116	_	_
19	23	and	and	CC	6	cc	2117	2120	_	_
19	24	the	the	DT	26	det	2121	2124	_	_
19	25	global	global	JJ	26	amod	2125	2131	_	_
19	26	coverage	coverage	NN	29	nsubj	2132	2140	_	_
19	27	is	be	VBZ	29	cop	2141	2143	_	_
19	28	39	39	CD	29	nummod	2144	2146	B-persongroup-8064	_
19	29	%	%	NN	6	conj	2146	2147	I-persongroup-8064	_
19	30	.	.	.	6	punct	2147	2148	I-persongroup-8064	_

20	1	Human	human	JJ	2	amod	2160	2165	_	_
20	2	papillomavirus	papillomavirus	NN	8	nsubj	2166	2180	_	_
20	3	is	be	VBZ	8	cop	2181	2183	_	_
20	4	the	the	DT	8	det	2184	2187	_	_
20	5	most	most	RBS	6	advmod	2188	2192	_	_
20	6	common	common	JJ	8	amod	2193	2199	_	_
20	7	viral	viral	JJ	8	amod	2200	2205	_	_
20	8	infection	infection	NN	0	ROOT	2206	2215	_	_
20	9	of	of	IN	12	case	2216	2218	_	_
20	10	the	the	DT	12	det	2219	2222	_	_
20	11	reproductive	reproductive	JJ	12	amod	2223	2235	_	_
20	12	tract	tract	NN	8	nmod	2236	2241	_	_
20	13	,	,	,	8	punct	2241	2242	_	_
20	14	and	and	CC	8	cc	2243	2246	_	_
20	15	can	can	MD	16	aux	2247	2250	_	_
20	16	cause	cause	VB	8	conj	2251	2256	_	_
20	17	cervical	cervical	JJ	18	amod	2257	2265	_	_
20	18	cancer	cancer	NN	16	dobj	2266	2272	_	_
20	19	,	,	,	18	punct	2272	2273	_	_
20	20	other	other	JJ	21	amod	2274	2279	_	_
20	21	types	type	NNS	18	conj	2280	2285	_	_
20	22	of	of	IN	23	case	2286	2288	_	_
20	23	cancer	cancer	NN	21	nmod	2289	2295	_	_
20	24	,	,	,	18	punct	2295	2296	_	_
20	25	and	and	CC	18	cc	2297	2300	_	_
20	26	genital	genital	JJ	27	amod	2301	2308	_	_
20	27	warts	wart	NNS	18	conj	2309	2314	_	_
20	28	in	in	IN	30	case	2315	2317	_	_
20	29	both	both	DT	30	cc:preconj	2318	2322	_	_
20	30	men	man	NNS	27	nmod	2323	2326	B-persongroup-8065	_
20	31	and	and	CC	30	cc	2327	2330	_	_
20	32	women	woman	NNS	30	conj	2331	2336	B-persongroup-8066	_
20	33	.	.	.	8	punct	2336	2337	I-persongroup-8066	_

21	1	Human	human	JJ	3	amod	2338	2343	_	_
21	2	papillomavirus	papillomavirus	NN	3	compound	2344	2358	_	_
21	3	vaccine	vaccine	NN	5	nsubjpass	2359	2366	_	_
21	4	was	be	VBD	5	auxpass	2367	2370	_	_
21	5	introduced	introduce	VBN	0	ROOT	2371	2381	_	_
21	6	in	in	IN	8	case	2382	2384	_	_
21	7	66	66	CD	8	nummod	2385	2387	B-persongroup-8067	_
21	8	countries	country	NNS	5	nmod	2388	2397	I-persongroup-8067	_
21	9	by	by	IN	11	case	2398	2400	_	_
21	10	the	the	DT	11	det	2401	2404	_	_
21	11	end	end	NN	5	nmod	2405	2408	_	_
21	12	of	of	IN	13	case	2409	2411	_	_
21	13	2015	2015	CD	11	nmod	2412	2416	_	_
21	14	.	.	.	5	punct	2416	2417	_	_

22	1	Measles	Measles	NNP	6	nsubj	2428	2435	_	_
22	2	is	be	VBZ	6	cop	2436	2438	_	_
22	3	a	a	DT	6	det	2439	2440	_	_
22	4	highly	highly	RB	5	advmod	2441	2447	_	_
22	5	contagious	contagious	JJ	6	amod	2448	2458	_	_
22	6	disease	disease	NN	0	ROOT	2459	2466	_	_
22	7	caused	cause	VBN	6	acl	2467	2473	_	_
22	8	by	by	IN	10	case	2474	2476	_	_
22	9	a	a	DT	10	det	2477	2478	_	_
22	10	virus	virus	NN	7	nmod	2479	2484	_	_
22	11	,	,	,	10	punct	2484	2485	_	_
22	12	which	which	WDT	14	nsubj	2486	2491	_	_
22	13	usually	usually	RB	14	advmod	2492	2499	_	_
22	14	results	result	VBZ	10	acl:relcl	2500	2507	_	_
22	15	in	in	IN	18	case	2508	2510	_	_
22	16	a	a	DT	18	det	2511	2512	_	_
22	17	high	high	JJ	18	amod	2513	2517	_	_
22	18	fever	fever	NN	14	nmod	2518	2523	_	_
22	19	and	and	CC	18	cc	2524	2527	_	_
22	20	rash	rash	NN	18	conj	2528	2532	_	_
22	21	,	,	,	14	punct	2532	2533	_	_
22	22	and	and	CC	14	cc	2534	2537	_	_
22	23	can	can	MD	24	aux	2538	2541	_	_
22	24	lead	lead	VB	14	conj	2542	2546	_	_
22	25	to	to	TO	26	case	2547	2549	_	_
22	26	blindness	blindness	NN	24	nmod	2550	2559	_	_
22	27	,	,	,	26	punct	2559	2560	_	_
22	28	encephalitis	encephalitis	NN	26	conj	2561	2573	_	_
22	29	or	or	CC	26	cc	2574	2576	_	_
22	30	death	death	NN	26	conj	2577	2582	_	_
22	31	.	.	.	6	punct	2582	2583	_	_

23	1	By	by	IN	3	case	2584	2586	_	_
23	2	the	the	DT	3	det	2587	2590	_	_
23	3	end	end	NN	12	nmod	2591	2594	_	_
23	4	of	of	IN	5	case	2595	2597	_	_
23	5	2015	2015	CD	3	nmod	2598	2602	_	_
23	6	,	,	,	12	punct	2602	2603	_	_
23	7	85	85	CD	8	nummod	2604	2606	B-persongroup-8068	_
23	8	%	%	NN	12	nsubj	2606	2607	I-persongroup-8068	_
23	9	of	of	IN	10	case	2608	2610	I-persongroup-8068	_
23	10	children	child	NNS	8	nmod	2611	2619	I-persongroup-8068	_
23	11	had	have	VBD	12	aux	2620	2623	_	_
23	12	received	receive	VBN	0	ROOT	2624	2632	_	_
23	13	1	1	CD	14	nummod	2633	2634	_	_
23	14	dose	dose	NN	12	dobj	2635	2639	_	_
23	15	of	of	IN	17	case	2640	2642	_	_
23	16	measles	measles	NNS	17	compound	2643	2650	_	_
23	17	vaccine	vaccine	NN	14	nmod	2651	2658	_	_
23	18	by	by	IN	21	case	2659	2661	_	_
23	19	their	they	PRP$	21	nmod:poss	2662	2667	B-persongroup-8069	_
23	20	second	second	JJ	21	amod	2668	2674	_	_
23	21	birthday	birthday	NN	12	nmod	2675	2683	_	_
23	22	,	,	,	12	punct	2683	2684	_	_
23	23	and	and	CC	12	cc	2685	2688	_	_
23	24	160	160	CD	25	nummod	2689	2692	B-persongroup-8070	_
23	25	countries	country	NNS	27	nsubj	2693	2702	I-persongroup-8070	_
23	26	had	have	VBD	27	aux	2703	2706	_	_
23	27	included	include	VBN	12	conj	2707	2715	_	_
23	28	a	a	DT	30	det	2716	2717	_	_
23	29	second	second	JJ	30	amod	2718	2724	_	_
23	30	dose	dose	NN	27	dobj	2725	2729	_	_
23	31	as	as	IN	32	case	2730	2732	_	_
23	32	part	part	NN	27	nmod	2733	2737	_	_
23	33	of	of	IN	35	case	2738	2740	_	_
23	34	routine	routine	JJ	35	amod	2741	2748	_	_
23	35	immunization	immunization	NN	32	nmod	2749	2761	_	_
23	36	and	and	CC	12	cc	2762	2765	_	_
23	37	61	61	CD	38	nummod	2766	2768	B-persongroup-8071	_
23	38	%	%	NN	41	nsubj	2768	2769	I-persongroup-8071	_
23	39	of	of	IN	40	case	2770	2772	I-persongroup-8071	_
23	40	children	child	NNS	38	nmod	2773	2781	I-persongroup-8071	_
23	41	received	receive	VBD	12	conj	2782	2790	_	_
23	42	2	2	CD	43	nummod	2791	2792	_	_
23	43	doses	dose	NNS	41	dobj	2793	2798	_	_
23	44	of	of	IN	46	case	2799	2801	_	_
23	45	measles	measles	NNS	46	compound	2802	2809	_	_
23	46	vaccine	vaccine	NN	43	nmod	2810	2817	_	_
23	47	according	accord	VBG	51	case	2818	2827	_	_
23	48	to	to	TO	47	mwe	2828	2830	_	_
23	49	national	national	JJ	51	amod	2831	2839	_	_
23	50	immunization	immunization	NN	51	compound	2840	2852	_	_
23	51	schedule	schedule	NN	41	nmod	2853	2861	_	_
23	52	.	.	.	12	punct	2861	2862	_	_

24	1	Meningitis	meningitis	NN	2	compound	2873	2883	_	_
24	2	A	a	NN	5	nsubj	2884	2885	_	_
24	3	is	be	VBZ	5	cop	2886	2888	_	_
24	4	an	a	DT	5	det	2889	2891	_	_
24	5	infection	infection	NN	0	ROOT	2892	2901	_	_
24	6	that	that	WDT	8	nsubj	2902	2906	_	_
24	7	can	can	MD	8	aux	2907	2910	_	_
24	8	cause	cause	VB	5	acl:relcl	2911	2916	_	_
24	9	severe	severe	JJ	11	amod	2917	2923	_	_
24	10	brain	brain	NN	11	compound	2924	2929	_	_
24	11	damage	damage	NN	8	dobj	2930	2936	_	_
24	12	and	and	CC	8	cc	2937	2940	_	_
24	13	is	be	VBZ	15	cop	2941	2943	_	_
24	14	often	often	RB	15	advmod	2944	2949	_	_
24	15	deadly	deadly	JJ	8	conj	2950	2956	_	_
24	16	.	.	.	5	punct	2956	2957	_	_

25	1	By	by	IN	3	case	2958	2960	_	_
25	2	the	the	DT	3	det	2961	2964	_	_
25	3	end	end	NN	27	nmod	2965	2968	_	_
25	4	of	of	IN	6	case	2969	2971	_	_
25	5	2015	2015	CD	6	nummod	2972	2976	_	_
25	6	–	–	CD	3	nmod	2977	2978	_	_
25	7	5	5	CD	8	nummod	2979	2980	_	_
25	8	years	year	NNS	6	nmod:tmod	2981	2986	_	_
25	9	after	after	IN	11	case	2987	2992	_	_
25	10	its	its	PRP$	11	nmod:poss	2993	2996	_	_
25	11	introduction	introduction	NN	6	nmod	2997	3009	_	_
25	12	–	–	CD	6	dep	3010	3011	_	_
25	13	more	more	JJR	16	advmod	3012	3016	B-persongroup-8072	_
25	14	than	than	IN	13	mwe	3017	3021	I-persongroup-8072	_
25	15	235	235	CD	16	compound	3023	3026	I-persongroup-8072	_
25	16	million	million	CD	17	nummod	3027	3034	I-persongroup-8072	_
25	17	people	people	NNS	27	nsubjpass	3035	3041	I-persongroup-8072	_
25	18	in	in	IN	20	case	3042	3044	_	_
25	19	African	african	JJ	20	amod	3045	3052	B-persongroup-8073	_
25	20	countries	country	NNS	17	nmod	3053	3062	I-persongroup-8073	_
25	21	affected	affect	VBN	20	acl	3063	3071	_	_
25	22	by	by	IN	24	case	3072	3074	_	_
25	23	the	the	DT	24	det	3075	3078	_	_
25	24	disease	disease	NN	21	nmod	3079	3086	_	_
25	25	had	have	VBD	27	aux	3087	3090	_	_
25	26	been	be	VBN	27	auxpass	3091	3095	_	_
25	27	vaccinated	vaccinate	VBN	0	ROOT	3096	3106	_	_
25	28	with	with	IN	29	case	3107	3111	_	_
25	29	MenAfriVac	MenAfriVac	NNP	27	nmod	3112	3122	_	_
25	30	,	,	,	29	punct	3122	3123	_	_
25	31	a	a	DT	32	det	3124	3125	_	_
25	32	vaccine	vaccine	NN	29	conj	3126	3133	_	_
25	33	developed	develop	VBN	32	acl	3134	3143	_	_
25	34	by	by	IN	35	case	3144	3146	_	_
25	35	WHO	who	WP	33	nmod	3147	3150	B-persongroup-8074	_
25	36	and	and	CC	29	cc	3151	3154	_	_
25	37	PATH	path	NN	29	conj	3155	3159	B-persongroup-8075	_
25	38	.	.	.	27	punct	3159	3160	I-persongroup-8075	_

26	1	Mumps	Mumps	NNP	6	nsubj	3171	3176	_	_
26	2	is	be	VBZ	6	cop	3177	3179	_	_
26	3	a	a	DT	6	det	3180	3181	_	_
26	4	highly	highly	RB	5	advmod	3182	3188	_	_
26	5	contagious	contagious	JJ	6	amod	3189	3199	_	_
26	6	virus	virus	NN	0	ROOT	3200	3205	_	_
26	7	that	that	WDT	8	nsubj	3206	3210	_	_
26	8	causes	cause	VBZ	6	acl:relcl	3211	3217	_	_
26	9	painful	painful	JJ	8	xcomp	3218	3225	_	_
26	10	swelling	swell	VBG	8	xcomp	3226	3234	_	_
26	11	at	at	IN	13	case	3235	3237	_	_
26	12	the	the	DT	13	det	3238	3241	_	_
26	13	side	side	NN	10	nmod	3242	3246	_	_
26	14	of	of	IN	16	case	3247	3249	_	_
26	15	the	the	DT	16	det	3250	3253	_	_
26	16	face	face	NN	13	nmod	3254	3258	_	_
26	17	under	under	IN	19	case	3259	3264	_	_
26	18	the	the	DT	19	det	3265	3268	_	_
26	19	ears	ear	NNS	10	nmod	3269	3273	_	_
26	20	(	(	VBP	19	acl:relcl	3274	3275	_	_
26	21	the	the	DT	23	det	3275	3278	_	_
26	22	parotid	parotid	JJ	23	amod	3279	3286	_	_
26	23	glands	gland	NNS	24	nsubj	3287	3293	_	_
26	24	)	)	VBP	20	ccomp	3293	3294	_	_
26	25	,	,	,	19	punct	3294	3295	_	_
26	26	fever	fever	NN	31	compound	3296	3301	_	_
26	27	,	,	,	26	punct	3301	3302	_	_
26	28	headache	headache	NN	26	conj	3303	3311	_	_
26	29	and	and	CC	26	cc	3312	3315	_	_
26	30	muscle	muscle	NN	26	conj	3316	3322	_	_
26	31	aches	ache	NNS	19	appos	3323	3328	_	_
26	32	.	.	.	6	punct	3328	3329	_	_

27	1	It	it	PRP	3	nsubj	3330	3332	_	_
27	2	can	can	MD	3	aux	3333	3336	_	_
27	3	lead	lead	VB	0	ROOT	3337	3341	_	_
27	4	to	to	TO	6	case	3342	3344	_	_
27	5	viral	viral	JJ	6	amod	3345	3350	_	_
27	6	meningitis	meningitis	NN	3	nmod	3351	3361	_	_
27	7	.	.	.	3	punct	3361	3362	_	_

28	1	Mumps	Mumps	NNP	2	compound	3363	3368	_	_
28	2	vaccine	vaccine	NN	5	nsubjpass	3369	3376	_	_
28	3	had	have	VBD	5	aux	3377	3380	_	_
28	4	been	be	VBN	5	auxpass	3381	3385	_	_
28	5	introduced	introduce	VBN	0	ROOT	3386	3396	_	_
28	6	nationwide	nationwide	JJ	5	advmod	3397	3407	_	_
28	7	in	in	IN	9	case	3408	3410	_	_
28	8	121	121	CD	9	nummod	3411	3414	B-persongroup-8076	_
28	9	countries	country	NNS	6	nmod	3415	3424	I-persongroup-8076	_
28	10	by	by	IN	12	case	3425	3427	_	_
28	11	the	the	DT	12	det	3428	3431	_	_
28	12	end	end	NN	5	nmod	3432	3435	_	_
28	13	of	of	IN	14	case	3436	3438	_	_
28	14	2015	2015	CD	12	nmod	3439	3443	_	_
28	15	.	.	.	5	punct	3443	3444	_	_

29	1	Pneumococcal	pneumococcal	JJ	2	amod	3455	3467	_	_
29	2	diseases	disease	NNS	3	nsubj	3468	3476	_	_
29	3	include	include	VBP	0	ROOT	3477	3484	_	_
29	4	pneumonia	pneumonia	NN	3	dobj	3485	3494	_	_
29	5	,	,	,	4	punct	3494	3495	_	_
29	6	meningitis	meningitis	NN	4	conj	3496	3506	_	_
29	7	and	and	CC	4	cc	3507	3510	_	_
29	8	febrile	febrile	JJ	9	amod	3511	3518	_	_
29	9	bacteraemia	bacteraemia	NN	4	conj	3519	3530	_	_
29	10	,	,	,	4	punct	3530	3531	_	_
29	11	as	as	RB	4	cc	3532	3534	_	_
29	12	well	well	RB	11	mwe	3535	3539	_	_
29	13	as	as	IN	11	mwe	3540	3542	_	_
29	14	otitis	otitis	NN	15	compound	3543	3549	_	_
29	15	media	media	NNS	4	conj	3550	3555	_	_
29	16	,	,	,	15	punct	3555	3556	_	_
29	17	sinusitis	sinusitis	NN	15	conj	3557	3566	_	_
29	18	and	and	CC	15	cc	3567	3570	_	_
29	19	bronchitis	bronchitis	NN	15	conj	3571	3581	_	_
29	20	.	.	.	3	punct	3581	3582	_	_

30	1	Pneumococcal	pneumococcal	JJ	2	amod	3583	3595	_	_
30	2	vaccine	vaccine	NN	5	nsubjpass	3596	3603	_	_
30	3	had	have	VBD	5	aux	3604	3607	_	_
30	4	been	be	VBN	5	auxpass	3608	3612	_	_
30	5	introduced	introduce	VBN	0	ROOT	3613	3623	_	_
30	6	in	in	IN	8	case	3624	3626	_	_
30	7	129	129	CD	8	nummod	3628	3631	B-persongroup-8077	_
30	8	countries	country	NNS	5	nmod	3632	3641	I-persongroup-8077	_
30	9	by	by	IN	11	case	3642	3644	_	_
30	10	the	the	DT	11	det	3645	3648	_	_
30	11	end	end	NN	5	nmod	3649	3652	_	_
30	12	of	of	IN	13	case	3653	3655	_	_
30	13	2015	2015	CD	11	nmod	3656	3660	_	_
30	14	,	,	,	5	punct	3660	3661	_	_
30	15	and	and	CC	5	cc	3662	3665	_	_
30	16	global	global	JJ	17	amod	3666	3672	_	_
30	17	coverage	coverage	NN	19	nsubjpass	3673	3681	_	_
30	18	was	be	VBD	19	auxpass	3682	3685	_	_
30	19	estimated	estimate	VBN	5	conj	3686	3695	_	_
30	20	at	at	IN	22	case	3696	3698	_	_
30	21	37	37	CD	22	nummod	3700	3702	B-persongroup-8078	_
30	22	%	%	NN	19	nmod	3702	3703	I-persongroup-8078	_
30	23	.	.	.	5	punct	3703	3704	I-persongroup-8078	_

31	1	Polio	Polio	NNP	7	nsubj	3715	3720	_	_
31	2	is	be	VBZ	7	cop	3721	3723	_	_
31	3	a	a	DT	7	det	3724	3725	_	_
31	4	highly	highly	RB	7	advmod	3726	3732	_	_
31	5	infectious	infectious	JJ	7	amod	3733	3743	_	_
31	6	viral	viral	JJ	7	amod	3744	3749	_	_
31	7	disease	disease	NN	0	ROOT	3750	3757	_	_
31	8	that	that	WDT	10	nsubj	3758	3762	_	_
31	9	can	can	MD	10	aux	3763	3766	_	_
31	10	cause	cause	VB	7	acl:relcl	3767	3772	_	_
31	11	irreversible	irreversible	JJ	12	amod	3773	3785	_	_
31	12	paralysis	paralysis	NN	10	dobj	3786	3795	_	_
31	13	.	.	.	7	punct	3795	3796	_	_

32	1	In	in	IN	2	case	3797	3799	_	_
32	2	2015	2015	CD	11	nmod	3800	3804	_	_
32	3	,	,	,	11	punct	3804	3805	_	_
32	4	86	86	CD	5	nummod	3806	3808	B-persongroup-8079	_
32	5	%	%	NN	11	nsubj	3808	3809	I-persongroup-8079	_
32	6	of	of	IN	7	case	3810	3812	I-persongroup-8079	_
32	7	infants	infant	NNS	5	nmod	3813	3820	I-persongroup-8079	_
32	8	around	around	IN	10	case	3821	3827	B-persongroup-8080	_
32	9	the	the	DT	10	det	3828	3831	I-persongroup-8080	_
32	10	world	world	NN	7	nmod	3832	3837	I-persongroup-8080	_
32	11	received	receive	VBD	0	ROOT	3838	3846	_	_
32	12	3	3	CD	13	nummod	3847	3848	_	_
32	13	doses	dose	NNS	11	dobj	3849	3854	_	_
32	14	of	of	IN	16	case	3855	3857	_	_
32	15	polio	polio	NNP	16	compound	3858	3863	_	_
32	16	vaccine	vaccine	NN	13	nmod	3864	3871	_	_
32	17	.	.	.	11	punct	3871	3872	_	_

33	1	Targeted	target	VBN	9	advcl	3873	3881	_	_
33	2	for	for	IN	4	case	3882	3885	_	_
33	3	global	global	JJ	4	amod	3886	3892	_	_
33	4	eradication	eradication	NN	1	nmod	3893	3904	_	_
33	5	,	,	,	9	punct	3904	3905	_	_
33	6	polio	polio	NNP	9	nsubjpass	3906	3911	_	_
33	7	has	have	VBZ	9	aux	3912	3915	_	_
33	8	been	be	VBN	9	auxpass	3916	3920	_	_
33	9	stopped	stop	VBN	0	ROOT	3921	3928	_	_
33	10	in	in	RP	9	compound:prt	3929	3931	_	_
33	11	all	all	DT	12	det	3932	3935	B-persongroup-8081	_
33	12	countries	country	NNS	9	dobj	3936	3945	I-persongroup-8081	_
33	13	except	except	IN	15	case	3946	3952	_	_
33	14	for	for	IN	15	case	3953	3956	_	_
33	15	2	2	CD	9	nmod	3957	3958	B-persongroup-8082	_
33	16	:	:	:	15	punct	3958	3959	I-persongroup-8082	_
33	17	Afghanistan	Afghanistan	NNP	15	dep	3960	3971	B-persongroup-8083	_
33	18	and	and	CC	17	cc	3972	3975	_	_
33	19	Pakistan	Pakistan	NNP	17	conj	3976	3984	B-persongroup-8084	_
33	20	.	.	.	9	punct	3984	3985	I-persongroup-8084	_

34	1	Polio-free	polio-free	JJ	2	amod	3986	3996	B-persongroup-8085	_
34	2	countries	country	NNS	5	nsubjpass	3997	4006	I-persongroup-8085	_
34	3	have	have	VBP	5	aux	4007	4011	_	_
34	4	been	be	VBN	5	auxpass	4012	4016	_	_
34	5	infected	infect	VBN	0	ROOT	4017	4025	_	_
34	6	by	by	IN	8	case	4026	4028	_	_
34	7	imported	import	VBN	8	amod	4029	4037	_	_
34	8	virus	virus	NN	5	nmod	4038	4043	_	_
34	9	,	,	,	5	punct	4043	4044	_	_
34	10	and	and	CC	5	cc	4045	4048	_	_
34	11	all	all	DT	12	det	4049	4052	B-persongroup-8086	_
34	12	countries	country	NNS	13	nsubj	4053	4062	I-persongroup-8086	_
34	13	–	–	VBP	5	conj	4063	4064	_	_
34	14	especially	especially	RB	15	advmod	4065	4075	_	_
34	15	those	those	DT	21	nsubj	4076	4081	B-persongroup-8087	_
34	16	experiencing	experience	VBG	15	acl	4082	4094	I-persongroup-8087	_
34	17	conflict	conflict	NN	16	iobj	4095	4103	I-persongroup-8087	_
34	18	and	and	CC	17	cc	4104	4107	I-persongroup-8087	_
34	19	instability	instability	NN	17	conj	4108	4119	I-persongroup-8087	_
34	20	–	–	CD	16	dobj	4120	4121	_	_
34	21	remain	remain	VBP	13	ccomp	4122	4128	_	_
34	22	at	at	IN	23	case	4129	4131	_	_
34	23	risk	risk	NN	21	nmod	4132	4136	_	_
34	24	until	until	IN	28	mark	4137	4142	_	_
34	25	polio	polio	NNP	28	nsubjpass	4143	4148	_	_
34	26	is	be	VBZ	28	auxpass	4149	4151	_	_
34	27	fully	fully	RB	28	advmod	4152	4157	_	_
34	28	eradicated	eradicate	VBN	21	advcl	4158	4168	_	_
34	29	.	.	.	5	punct	4168	4169	_	_

35	1	Rotaviruses	rotavirus	NNS	6	nsubj	4181	4192	_	_
35	2	are	be	VBP	6	cop	4193	4196	_	_
35	3	the	the	DT	6	det	4197	4200	_	_
35	4	most	most	RBS	5	advmod	4201	4205	_	_
35	5	common	common	JJ	6	amod	4206	4212	_	_
35	6	cause	cause	NN	0	ROOT	4213	4218	_	_
35	7	of	of	IN	10	case	4219	4221	_	_
35	8	severe	severe	JJ	10	amod	4222	4228	_	_
35	9	diarrhoeal	diarrhoeal	NN	10	compound	4229	4239	_	_
35	10	disease	disease	NN	6	nmod	4240	4247	_	_
35	11	in	in	IN	13	case	4248	4250	_	_
35	12	young	young	JJ	13	amod	4251	4256	B-persongroup-8088	_
35	13	children	child	NNS	10	nmod	4257	4265	I-persongroup-8088	_
35	14	throughout	throughout	IN	16	case	4266	4276	B-persongroup-8089	_
35	15	the	the	DT	16	det	4277	4280	I-persongroup-8089	_
35	16	world	world	NN	13	nmod	4281	4286	I-persongroup-8089	_
35	17	.	.	.	6	punct	4286	4287	I-persongroup-8089	_

36	1	Rotavirus	Rotavirus	NNP	2	compound	4288	4297	_	_
36	2	vaccine	vaccine	NN	4	nsubjpass	4298	4305	_	_
36	3	was	be	VBD	4	auxpass	4306	4309	_	_
36	4	introduced	introduce	VBN	0	ROOT	4310	4320	_	_
36	5	in	in	IN	7	case	4321	4323	_	_
36	6	84	84	CD	7	nummod	4325	4327	B-persongroup-8090	_
36	7	countries	country	NNS	4	nmod	4328	4337	I-persongroup-8090	_
36	8	by	by	IN	10	case	4338	4340	_	_
36	9	the	the	DT	10	det	4341	4344	_	_
36	10	end	end	NN	4	nmod	4345	4348	_	_
36	11	of	of	IN	12	case	4349	4351	_	_
36	12	2015	2015	CD	10	nmod	4352	4356	_	_
36	13	,	,	,	4	punct	4356	4357	_	_
36	14	and	and	CC	4	cc	4358	4361	_	_
36	15	global	global	JJ	16	amod	4362	4368	_	_
36	16	coverage	coverage	NN	18	nsubjpass	4369	4377	_	_
36	17	was	be	VBD	18	auxpass	4378	4381	_	_
36	18	estimated	estimate	VBN	4	conj	4382	4391	_	_
36	19	at	at	IN	21	case	4392	4394	_	_
36	20	23	23	CD	21	nummod	4396	4398	B-persongroup-8091	_
36	21	%	%	NN	18	nmod	4398	4399	I-persongroup-8091	_
36	22	.	.	.	4	punct	4399	4400	I-persongroup-8091	_

37	1	Rubella	Rubella	NNP	5	nsubj	4411	4418	_	_
37	2	is	be	VBZ	5	cop	4419	4421	_	_
37	3	a	a	DT	5	det	4422	4423	_	_
37	4	viral	viral	JJ	5	amod	4424	4429	_	_
37	5	disease	disease	NN	0	ROOT	4430	4437	_	_
37	6	which	which	WDT	9	nsubj	4438	4443	_	_
37	7	is	be	VBZ	9	cop	4444	4446	_	_
37	8	usually	usually	RB	9	advmod	4447	4454	_	_
37	9	mild	mild	JJ	5	acl:relcl	4455	4459	_	_
37	10	in	in	IN	11	case	4460	4462	_	_
37	11	children	child	NNS	9	nmod	4463	4471	B-persongroup-8092	_
37	12	,	,	,	5	punct	4471	4472	I-persongroup-8092	_
37	13	but	but	CC	5	cc	4473	4476	_	_
37	14	infection	infection	NN	19	nsubj	4477	4486	_	_
37	15	during	during	IN	17	case	4487	4493	_	_
37	16	early	early	JJ	17	amod	4494	4499	_	_
37	17	pregnancy	pregnancy	NN	14	nmod	4500	4509	_	_
37	18	may	may	MD	19	aux	4510	4513	_	_
37	19	cause	cause	VB	5	conj	4514	4519	_	_
37	20	fetal	fetal	JJ	21	amod	4520	4525	_	_
37	21	death	death	NN	19	dobj	4526	4531	_	_
37	22	or	or	CC	21	cc	4532	4534	_	_
37	23	congenital	congenital	JJ	25	amod	4535	4545	_	_
37	24	rubella	rubella	NN	25	compound	4546	4553	_	_
37	25	syndrome	syndrome	NN	21	conj	4554	4562	_	_
37	26	,	,	,	21	punct	4562	4563	_	_
37	27	which	which	WDT	29	nsubj	4564	4569	_	_
37	28	can	can	MD	29	aux	4570	4573	_	_
37	29	lead	lead	VB	21	acl:relcl	4574	4578	_	_
37	30	to	to	TO	31	case	4579	4581	_	_
37	31	defects	defect	NNS	29	nmod	4582	4589	_	_
37	32	of	of	IN	34	case	4590	4592	_	_
37	33	the	the	DT	34	det	4593	4596	_	_
37	34	brain	brain	NN	31	nmod	4597	4602	_	_
37	35	,	,	,	34	punct	4602	4603	_	_
37	36	heart	heart	NN	34	conj	4604	4609	_	_
37	37	,	,	,	34	punct	4609	4610	_	_
37	38	eyes	eye	NNS	34	conj	4611	4615	_	_
37	39	and	and	CC	34	cc	4616	4619	_	_
37	40	ears	ear	NNS	34	conj	4620	4624	_	_
37	41	.	.	.	5	punct	4624	4625	_	_

38	1	Rubella	rubella	NN	2	compound	4626	4633	_	_
38	2	vaccine	vaccine	NN	4	nsubjpass	4634	4641	_	_
38	3	was	be	VBD	4	auxpass	4642	4645	_	_
38	4	introduced	introduce	VBN	0	ROOT	4646	4656	_	_
38	5	nationwide	nationwide	JJ	4	advmod	4657	4667	_	_
38	6	in	in	IN	8	case	4668	4670	_	_
38	7	147	147	CD	8	nummod	4672	4675	B-persongroup-8093	_
38	8	countries	country	NNS	5	nmod	4676	4685	I-persongroup-8093	_
38	9	by	by	IN	11	case	4686	4688	_	_
38	10	the	the	DT	11	det	4689	4692	_	_
38	11	end	end	NN	4	nmod	4693	4696	_	_
38	12	of	of	IN	13	case	4697	4699	_	_
38	13	2015	2015	CD	11	nmod	4700	4704	_	_
38	14	and	and	CC	4	cc	4705	4708	_	_
38	15	global	global	JJ	16	amod	4709	4715	_	_
38	16	coverage	coverage	NN	18	nsubjpass	4716	4724	_	_
38	17	was	be	VBD	18	auxpass	4725	4728	_	_
38	18	estimated	estimate	VBN	4	conj	4729	4738	_	_
38	19	at	at	IN	21	case	4739	4741	_	_
38	20	46	46	CD	21	nummod	4742	4744	B-persongroup-8094	_
38	21	%	%	NN	18	nmod	4744	4745	I-persongroup-8094	_
38	22	.	.	.	4	punct	4745	4746	I-persongroup-8094	_

39	1	Tetanus	tetanus	NN	3	nsubjpass	4757	4764	_	_
39	2	is	be	VBZ	3	auxpass	4765	4767	_	_
39	3	caused	cause	VBN	0	ROOT	4768	4774	_	_
39	4	by	by	IN	6	case	4775	4777	_	_
39	5	a	a	DT	6	det	4778	4779	_	_
39	6	bacterium	bacterium	NN	3	nmod	4780	4789	_	_
39	7	which	which	WDT	8	nsubj	4790	4795	_	_
39	8	grows	grow	VBZ	6	acl:relcl	4796	4801	_	_
39	9	in	in	IN	11	case	4802	4804	_	_
39	10	the	the	DT	11	det	4805	4808	_	_
39	11	absence	absence	NN	8	nmod	4809	4816	_	_
39	12	of	of	IN	13	case	4817	4819	_	_
39	13	oxygen	oxygen	NN	11	nmod	4820	4826	_	_
39	14	,	,	,	11	punct	4826	4827	_	_
39	15	for	for	IN	16	case	4828	4831	_	_
39	16	example	example	NN	11	conj	4832	4839	_	_
39	17	in	in	IN	19	case	4840	4842	_	_
39	18	dirty	dirty	JJ	19	amod	4843	4848	_	_
39	19	wounds	wound	NNS	16	nmod	4849	4855	_	_
39	20	or	or	CC	11	cc	4856	4858	_	_
39	21	in	in	IN	24	case	4859	4861	_	_
39	22	the	the	DT	24	det	4862	4865	_	_
39	23	umbilical	umbilical	JJ	24	amod	4866	4875	_	_
39	24	cord	cord	NN	11	conj	4876	4880	_	_
39	25	if	if	IN	29	mark	4881	4883	_	_
39	26	it	it	PRP	29	nsubjpass	4884	4886	_	_
39	27	is	be	VBZ	29	auxpass	4887	4889	_	_
39	28	not	not	RB	29	neg	4890	4893	_	_
39	29	kept	keep	VBN	8	advcl	4894	4898	_	_
39	30	clean	clean	JJ	29	xcomp	4899	4904	_	_
39	31	.	.	.	3	punct	4904	4905	_	_

40	1	It	it	PRP	2	nsubj	4906	4908	_	_
40	2	produces	produce	VBZ	0	ROOT	4909	4917	_	_
40	3	a	a	DT	4	det	4918	4919	_	_
40	4	toxin	toxin	NN	2	dobj	4920	4925	_	_
40	5	which	which	WDT	7	nsubj	4926	4931	_	_
40	6	can	can	MD	7	aux	4932	4935	_	_
40	7	cause	cause	VB	4	acl:relcl	4936	4941	_	_
40	8	serious	serious	JJ	9	amod	4942	4949	_	_
40	9	complications	complication	NNS	7	dobj	4950	4963	_	_
40	10	or	or	CC	9	cc	4964	4966	_	_
40	11	death	death	NN	9	conj	4967	4972	_	_
40	12	.	.	.	2	punct	4972	4973	_	_

41	1	The	the	DT	2	det	4974	4977	_	_
41	2	vaccine	vaccine	NN	11	nsubjpass	4978	4985	_	_
41	3	to	to	TO	4	mark	4986	4988	_	_
41	4	prevent	prevent	VB	2	acl	4989	4996	_	_
41	5	maternal	maternal	JJ	8	amod	4997	5005	_	_
41	6	and	and	CC	5	cc	5006	5009	_	_
41	7	neonatal	neonatal	JJ	5	conj	5010	5018	_	_
41	8	tetanus	tetanus	NN	4	dobj	5019	5026	_	_
41	9	had	have	VBD	11	aux	5027	5030	_	_
41	10	been	be	VBN	11	auxpass	5031	5035	_	_
41	11	introduced	introduce	VBN	0	ROOT	5036	5046	_	_
41	12	in	in	IN	14	case	5047	5049	_	_
41	13	106	106	CD	14	nummod	5050	5053	B-persongroup-8095	_
41	14	countries	country	NNS	11	nmod	5054	5063	I-persongroup-8095	_
41	15	by	by	IN	17	case	5064	5066	_	_
41	16	the	the	DT	17	det	5067	5070	_	_
41	17	end	end	NN	11	nmod	5071	5074	_	_
41	18	of	of	IN	19	case	5075	5077	_	_
41	19	2015	2015	CD	17	nmod	5078	5082	_	_
41	20	.	.	.	11	punct	5082	5083	_	_

42	1	An	a	DT	4	det	5084	5086	_	_
42	2	estimated	estimate	VBN	4	amod	5087	5096	_	_
42	3	83	83	CD	4	nummod	5097	5099	B-persongroup-8096	_
42	4	%	%	NN	8	nsubjpass	5099	5100	I-persongroup-8096	_
42	5	of	of	IN	6	case	5101	5103	I-persongroup-8096	_
42	6	newborns	newborn	NNS	4	nmod	5104	5112	I-persongroup-8096	_
42	7	were	be	VBD	8	auxpass	5113	5117	_	_
42	8	protected	protect	VBN	0	ROOT	5118	5127	_	_
42	9	through	through	IN	10	case	5128	5135	_	_
42	10	immunization	immunization	NN	8	nmod	5136	5148	_	_
42	11	.	.	.	8	punct	5148	5149	_	_

43	1	Maternal	maternal	JJ	4	amod	5150	5158	_	_
43	2	and	and	CC	1	cc	5159	5162	_	_
43	3	neonatal	neonatal	JJ	1	conj	5163	5171	_	_
43	4	tetanus	tetanus	NN	5	nsubj	5172	5179	_	_
43	5	persist	persist	VBP	0	ROOT	5180	5187	_	_
43	6	as	as	IN	9	case	5188	5190	_	_
43	7	public	public	JJ	9	amod	5191	5197	_	_
43	8	health	health	NN	9	compound	5198	5204	_	_
43	9	problems	problem	NNS	5	nmod	5205	5213	_	_
43	10	in	in	IN	12	case	5214	5216	_	_
43	11	19	19	CD	12	nummod	5217	5219	B-persongroup-8097	_
43	12	countries	country	NNS	9	nmod	5220	5229	I-persongroup-8097	_
43	13	,	,	,	9	punct	5229	5230	I-persongroup-8097	_
43	14	mainly	mainly	RB	9	advmod	5231	5237	_	_
43	15	in	in	IN	16	case	5238	5240	_	_
43	16	Africa	Africa	NNP	5	nmod	5241	5247	B-persongroup-8098	_
43	17	and	and	CC	16	cc	5248	5251	_	_
43	18	Asia	Asia	NNP	16	conj	5252	5256	B-persongroup-8099	_
43	19	.	.	.	5	punct	5256	5257	I-persongroup-8099	_

44	1	Yellow	yellow	JJ	2	amod	5268	5274	_	_
44	2	fever	fever	NN	8	nsubj	5275	5280	_	_
44	3	is	be	VBZ	8	cop	5281	5283	_	_
44	4	an	a	DT	8	det	5284	5286	_	_
44	5	acute	acute	JJ	8	amod	5287	5292	_	_
44	6	viral	viral	JJ	8	amod	5293	5298	_	_
44	7	haemorrhagic	haemorrhagic	JJ	8	amod	5299	5311	_	_
44	8	disease	disease	NN	0	ROOT	5312	5319	_	_
44	9	transmitted	transmit	VBN	8	acl	5320	5331	_	_
44	10	by	by	IN	12	case	5332	5334	_	_
44	11	infected	infected	JJ	12	amod	5335	5343	_	_
44	12	mosquitoes	mosquito	NNS	9	nmod	5344	5354	_	_
44	13	.	.	.	8	punct	5354	5355	_	_

45	1	As	as	IN	3	case	5356	5358	_	_
45	2	of	of	IN	3	case	5359	5361	_	_
45	3	2015	2015	CD	10	nmod	5362	5366	_	_
45	4	,	,	,	10	punct	5366	5367	_	_
45	5	yellow	yellow	JJ	7	amod	5368	5374	_	_
45	6	fever	fever	NN	7	compound	5375	5380	_	_
45	7	vaccine	vaccine	NN	10	nsubjpass	5381	5388	_	_
45	8	had	have	VBD	10	aux	5389	5392	_	_
45	9	been	be	VBN	10	auxpass	5393	5397	_	_
45	10	introduced	introduce	VBN	0	ROOT	5398	5408	_	_
45	11	in	in	IN	15	case	5409	5411	_	_
45	12	routine	routine	JJ	15	amod	5412	5419	_	_
45	13	infant	infant	NN	15	compound	5420	5426	B-persongroup-8100	_
45	14	immunization	immunization	NN	15	compound	5427	5439	_	_
45	15	programmes	programme	NNS	10	nmod	5440	5450	_	_
45	16	in	in	IN	17	case	5451	5453	_	_
45	17	35	35	CD	10	nmod	5454	5456	B-persongroup-8101	_
45	18	of	of	IN	21	case	5457	5459	I-persongroup-8101	_
45	19	the	the	DT	21	det	5460	5463	I-persongroup-8101	_
45	20	42	42	CD	21	nummod	5465	5467	I-persongroup-8101	_
45	21	countries	country	NNS	17	nmod	5468	5477	I-persongroup-8101	_
45	22	and	and	CC	21	cc	5478	5481	I-persongroup-8101	_
45	23	territories	territory	NNS	21	conj	5482	5493	I-persongroup-8101	_
45	24	at	at	IN	25	case	5494	5496	_	_
45	25	risk	risk	NN	10	nmod	5497	5501	_	_
45	26	for	for	IN	28	case	5502	5505	_	_
45	27	yellow	yellow	JJ	28	amod	5506	5512	_	_
45	28	fever	fever	NN	25	nmod	5513	5518	_	_
45	29	in	in	IN	30	case	5519	5521	_	_
45	30	Africa	Africa	NNP	28	nmod	5522	5528	B-persongroup-8102	_
45	31	and	and	CC	30	cc	5529	5532	_	_
45	32	the	the	DT	33	det	5533	5536	_	_
45	33	Americas	Americas	NNPS	30	conj	5537	5545	B-persongroup-8103	_
45	34	.	.	.	10	punct	5545	5546	I-persongroup-8103	_

46	1	Last	last	JJ	2	amod	5557	5561	_	_
46	2	year	year	NN	15	nmod:tmod	5562	5566	_	_
46	3	,	,	,	15	punct	5566	5567	_	_
46	4	the	the	DT	7	det	5568	5571	B-persongroup-8104	_
46	5	Strategic	Strategic	NNP	7	compound	5572	5581	I-persongroup-8104	_
46	6	Advisory	Advisory	NNP	7	compound	5582	5590	I-persongroup-8104	_
46	7	Group	Group	NNP	15	nsubj	5591	5596	I-persongroup-8104	_
46	8	of	of	IN	9	case	5597	5599	I-persongroup-8104	_
46	9	Experts	expert	NNS	7	nmod	5600	5607	I-persongroup-8104	_
46	10	on	on	IN	14	case	5608	5610	I-persongroup-8104	_
46	11	immunization	immunization	NN	14	compound	5611	5623	I-persongroup-8104	_
46	12	(	(	CD	14	nummod	5624	5625	I-persongroup-8104	_
46	13	SAGE	sage	NN	14	compound	5625	5629	I-persongroup-8104	_
46	14	)	)	NN	9	nmod	5629	5630	I-persongroup-8104	_
46	15	identified	identify	VBD	0	ROOT	5631	5641	_	_
46	16	5	5	CD	17	nummod	5642	5643	_	_
46	17	factors	factor	NNS	15	dobj	5644	5651	_	_
46	18	to	to	TO	19	mark	5652	5654	_	_
46	19	achieving	achieve	VBG	17	acl	5655	5664	_	_
46	20	results	result	NNS	19	dobj	5665	5672	_	_
46	21	in	in	IN	23	case	5673	5675	_	_
46	22	immunization	immunization	NN	23	compound	5676	5688	_	_
46	23	coverage	coverage	NN	20	nmod	5689	5697	_	_
46	24	:	:	:	20	punct	5697	5698	_	_
46	25	access	access	NN	20	dep	5699	5705	_	B-expressionPos-8150
46	26	to	to	TO	27	case	5706	5708	_	I-expressionPos-8150
46	27	vaccines	vaccine	NNS	25	nmod	5709	5717	_	I-expressionPos-8150
46	28	in	in	IN	30	case	5718	5720	_	I-expressionPos-8150
46	29	all	all	DT	30	det	5721	5724	B-persongroup-8105	I-expressionPos-8150
46	30	places	place	NNS	27	nmod	5725	5731	I-persongroup-8105	I-expressionPos-8150
46	31	at	at	IN	33	case	5732	5734	_	I-expressionPos-8150
46	32	all	all	DT	33	det	5735	5738	_	I-expressionPos-8150
46	33	times	time	NNS	19	nmod	5739	5744	_	I-expressionPos-8150
46	34	.	.	.	15	punct	5744	5745	_	I-expressionPos-8150

47	1	In	in	IN	2	case	5756	5758	_	_
47	2	2015	2015	CD	12	nmod	5760	5764	_	_
47	3	,	,	,	12	punct	5764	5765	_	_
47	4	an	a	DT	8	det	5766	5768	_	_
47	5	estimated	estimate	VBN	8	amod	5769	5778	_	_
47	6	19.4	19.4	CD	7	compound	5779	5783	B-persongroup-8106	_
47	7	million	million	CD	8	nummod	5784	5791	I-persongroup-8106	_
47	8	infants	infant	NNS	12	nsubjpass	5792	5799	I-persongroup-8106	_
47	9	worldwide	worldwide	JJ	12	advmod	5800	5809	I-persongroup-8106	_
47	10	were	be	VBD	12	auxpass	5810	5814	_	_
47	11	not	not	RB	12	neg	5815	5818	_	_
47	12	reached	reach	VBN	0	ROOT	5819	5826	_	_
47	13	with	with	IN	16	case	5827	5831	_	_
47	14	routine	routine	JJ	16	amod	5832	5839	_	_
47	15	immunization	immunization	NN	16	compound	5840	5852	_	_
47	16	services	service	NNS	12	nmod	5853	5861	_	_
47	17	such	such	JJ	20	case	5862	5866	_	_
47	18	as	as	IN	17	mwe	5867	5869	_	_
47	19	DTP3	dtp3	NN	20	compound	5870	5874	_	_
47	20	vaccine	vaccine	NN	16	nmod	5875	5882	_	_
47	21	.	.	.	12	punct	5882	5883	_	_

48	1	Around	around	IN	3	case	5884	5890	B-persongroup-8107	_
48	2	60	60	CD	3	nummod	5891	5893	I-persongroup-8107	_
48	3	%	%	NN	7	nmod	5893	5894	I-persongroup-8107	_
48	4	of	of	IN	6	case	5895	5897	I-persongroup-8107	_
48	5	these	these	DT	6	det	5898	5903	I-persongroup-8107	_
48	6	children	child	NNS	3	nmod	5904	5912	I-persongroup-8107	_
48	7	live	live	VBP	12	dep	5913	5917	_	_
48	8	in	in	IN	10	case	5918	5920	_	_
48	9	10	10	CD	10	nummod	5921	5923	B-persongroup-8108	_
48	10	countries	country	NNS	7	nmod	5924	5933	I-persongroup-8108	_
48	11	:	:	:	12	punct	5933	5934	I-persongroup-8108	_
48	12	Angola	Angola	NNP	0	ROOT	5935	5941	B-persongroup-8109	_
48	13	,	,	,	12	punct	5941	5942	I-persongroup-8109	_
48	14	the	the	DT	16	det	5943	5946	B-persongroup-8110	_
48	15	Democratic	democratic	JJ	16	amod	5947	5957	I-persongroup-8110	_
48	16	Republic	republic	NN	12	appos	5958	5966	I-persongroup-8110	_
48	17	of	of	IN	31	case	5967	5969	I-persongroup-8110	_
48	18	the	the	DT	31	det	5970	5973	I-persongroup-8110	_
48	19	Congo	Congo	NNP	31	compound	5974	5979	I-persongroup-8110	_
48	20	,	,	,	31	punct	5979	5980	I-persongroup-8110	_
48	21	Ethiopia	Ethiopia	NNP	31	appos	5981	5989	B-persongroup-8111	_
48	22	,	,	,	31	punct	5989	5990	I-persongroup-8111	_
48	23	India	India	NNP	31	appos	5991	5996	B-persongroup-8112	_
48	24	,	,	,	31	punct	5996	5997	I-persongroup-8112	_
48	25	Indonesia	Indonesia	NNP	31	appos	5998	6007	B-persongroup-8113	_
48	26	,	,	,	31	punct	6007	6008	I-persongroup-8113	_
48	27	Iraq	Iraq	NNP	31	appos	6009	6013	B-persongroup-8114	_
48	28	,	,	,	31	punct	6013	6014	I-persongroup-8114	_
48	29	Nigeria	Nigeria	NNP	31	appos	6015	6022	B-persongroup-8115	_
48	30	,	,	,	31	punct	6022	6023	I-persongroup-8115	_
48	31	Pakistan	Pakistan	NNP	16	nmod	6024	6032	B-persongroup-8116	_
48	32	,	,	,	31	punct	6032	6033	I-persongroup-8116	_
48	33	the	the	DT	34	det	6034	6037	B-persongroup-8117	_
48	34	Philippines	Philippines	NNPS	31	conj	6038	6049	I-persongroup-8117	_
48	35	,	,	,	31	punct	6049	6050	I-persongroup-8117	_
48	36	and	and	CC	31	cc	6051	6054	_	_
48	37	Ukraine	Ukraine	NNP	31	conj	6055	6062	B-persongroup-8118	_
48	38	.	.	.	12	punct	6062	6063	I-persongroup-8118	_

49	1	Monitoring	monitoring	NN	2	compound	6074	6084	_	B-expressionPos-8149
49	2	data	datum	NNS	7	nsubj	6085	6089	_	I-expressionPos-8149
49	3	at	at	IN	5	case	6090	6092	_	I-expressionPos-8149
49	4	subnational	subnational	JJ	5	amod	6093	6104	_	I-expressionPos-8149
49	5	levels	level	NNS	2	nmod	6105	6111	_	I-expressionPos-8149
49	6	is	be	VBZ	7	cop	6112	6114	_	I-expressionPos-8149
49	7	critical	critical	JJ	0	ROOT	6115	6123	_	I-expressionPos-8149
49	8	to	to	TO	9	mark	6124	6126	_	I-expressionPos-8149
49	9	helping	help	VBG	7	advcl	6127	6134	_	I-expressionPos-8149
49	10	countries	country	NNS	11	nsubj	6135	6144	B-persongroup-8119	I-expressionPos-8149
49	11	prioritize	prioritize	VB	9	ccomp	6145	6155	_	I-expressionPos-8149
49	12	and	and	CC	11	cc	6156	6159	_	I-expressionPos-8149
49	13	tailor	tailor	VB	11	conj	6160	6166	_	I-expressionPos-8149
49	14	vaccination	vaccination	NN	15	compound	6167	6178	_	I-expressionPos-8149
49	15	strategies	strategy	NNS	11	dobj	6179	6189	_	I-expressionPos-8149
49	16	and	and	CC	15	cc	6190	6193	_	I-expressionPos-8149
49	17	operational	operational	JJ	18	amod	6194	6205	_	I-expressionPos-8149
49	18	plans	plan	NNS	15	conj	6206	6211	_	I-expressionPos-8149
49	19	to	to	TO	20	mark	6212	6214	_	I-expressionPos-8149
49	20	address	address	VB	11	advcl	6215	6222	_	I-expressionPos-8149
49	21	immunization	immunization	NN	22	compound	6223	6235	_	I-expressionPos-8149
49	22	gaps	gap	NNS	20	dobj	6236	6240	_	I-expressionPos-8149
49	23	and	and	CC	11	cc	6241	6244	_	I-expressionPos-8149
49	24	reach	reach	VB	11	conj	6245	6250	_	I-expressionPos-8149
49	25	every	every	DT	26	det	6251	6256	B-persongroup-8120	I-expressionPos-8149
49	26	person	person	NN	24	dobj	6257	6263	I-persongroup-8120	I-expressionPos-8149
49	27	with	with	IN	29	case	6264	6268	_	I-expressionPos-8149
49	28	lifesaving	lifesaving	JJ	29	amod	6269	6279	_	I-expressionPos-8149
49	29	vaccines	vaccine	NNS	24	nmod	6280	6288	_	I-expressionPos-8149
49	30	.	.	.	7	punct	6288	6289	_	I-expressionPos-8149

50	1	WHO	who	WP	3	nsubj	6301	6304	B-persongroup-8121	_
50	2	is	be	VBZ	3	aux	6305	6307	_	_
50	3	working	work	VBG	0	ROOT	6308	6315	_	_
50	4	with	with	IN	5	case	6316	6320	_	_
50	5	countries	country	NNS	3	nmod	6321	6330	B-persongroup-8122	_
50	6	and	and	CC	5	cc	6331	6334	_	_
50	7	partners	partner	NNS	5	conj	6335	6343	B-persongroup-8123	_
50	8	to	to	TO	9	mark	6344	6346	_	_
50	9	improve	improve	VB	3	xcomp	6347	6354	_	_
50	10	global	global	JJ	12	amod	6355	6361	_	_
50	11	vaccination	vaccination	NN	12	compound	6362	6373	_	_
50	12	coverage	coverage	NN	9	dobj	6374	6382	_	_
50	13	,	,	,	3	punct	6382	6383	_	_
50	14	including	include	VBG	17	case	6384	6393	_	_
50	15	through	through	IN	17	case	6394	6401	_	_
50	16	these	these	DT	17	det	6402	6407	_	_
50	17	initiatives	initiative	NNS	3	advcl	6408	6419	_	_
50	18	adopted	adopt	VBN	17	acl	6420	6427	_	_
50	19	by	by	IN	23	case	6428	6430	_	_
50	20	the	the	DT	23	det	6431	6434	B-persongroup-8124	_
50	21	World	World	NNP	23	compound	6435	6440	I-persongroup-8124	_
50	22	Health	Health	NNP	23	compound	6441	6447	I-persongroup-8124	_
50	23	Assembly	Assembly	NNP	18	nmod	6448	6456	I-persongroup-8124	_
50	24	in	in	IN	25	case	6457	6459	_	_
50	25	May	May	NNP	23	nmod	6460	6463	_	_
50	26	2012	2012	CD	25	nummod	6464	6468	_	_
50	27	.	.	.	3	punct	6468	6469	_	_

51	1	The	the	DT	5	det	6480	6483	_	B-expressionPos-8148
51	2	Global	global	JJ	5	amod	6484	6490	_	I-expressionPos-8148
51	3	Vaccine	Vaccine	NNP	5	compound	6491	6498	_	I-expressionPos-8148
51	4	Action	Action	NNP	5	compound	6499	6505	_	I-expressionPos-8148
51	5	Plan	Plan	NNP	11	nsubj	6506	6510	_	I-expressionPos-8148
51	6	(	(	CD	8	nummod	6511	6512	_	I-expressionPos-8148
51	7	GVAP	gvap	NN	8	compound	6512	6516	_	I-expressionPos-8148
51	8	)	)	NN	5	dep	6516	6517	_	I-expressionPos-8148
51	9	is	be	VBZ	11	cop	6518	6520	_	I-expressionPos-8148
51	10	a	a	DT	11	det	6521	6522	_	I-expressionPos-8148
51	11	roadmap	roadmap	NN	0	ROOT	6523	6530	_	I-expressionPos-8148
51	12	to	to	TO	13	mark	6531	6533	_	I-expressionPos-8148
51	13	prevent	prevent	VB	11	acl	6534	6541	_	I-expressionPos-8148
51	14	millions	million	NNS	13	dobj	6542	6550	B-persongroup-8125	I-expressionPos-8148
51	15	of	of	IN	16	case	6551	6553	I-persongroup-8125	I-expressionPos-8148
51	16	deaths	death	NNS	14	nmod	6554	6560	I-persongroup-8125	I-expressionPos-8148
51	17	through	through	IN	20	case	6561	6568	_	I-expressionPos-8148
51	18	more	more	JJR	19	dep	6569	6573	_	I-expressionPos-8148
51	19	equitable	equitable	JJ	20	amod	6574	6583	_	I-expressionPos-8148
51	20	access	access	NN	13	nmod	6584	6590	_	I-expressionPos-8148
51	21	to	to	TO	22	case	6591	6593	_	I-expressionPos-8148
51	22	vaccines	vaccine	NNS	13	nmod	6594	6602	_	I-expressionPos-8148
51	23	.	.	.	11	punct	6602	6603	_	I-expressionPos-8148

52	1	Countries	country	NNS	3	nsubj	6604	6613	B-persongroup-8126	_
52	2	are	be	VBP	3	aux	6614	6617	_	_
52	3	aiming	aim	VBG	0	ROOT	6618	6624	_	_
52	4	to	to	TO	5	mark	6625	6627	_	_
52	5	achieve	achieve	VB	3	xcomp	6628	6635	_	_
52	6	vaccination	vaccination	NN	7	compound	6636	6647	_	_
52	7	coverage	coverage	NN	5	dobj	6648	6656	_	_
52	8	of	of	IN	12	case	6657	6659	_	_
52	9	at	at	IN	10	case	6660	6662	_	_
52	10	least	least	JJS	11	nmod:npmod	6663	6668	_	_
52	11	90	90	CD	12	nummod	6669	6671	B-persongroup-8127	_
52	12	%	%	NN	7	nmod	6671	6672	I-persongroup-8127	_
52	13	nationally	nationally	RB	12	advmod	6673	6683	I-persongroup-8127	_
52	14	and	and	CC	7	cc	6684	6687	_	_
52	15	at	at	IN	16	case	6688	6690	_	_
52	16	least	least	JJS	17	nmod:npmod	6691	6696	_	_
52	17	80	80	CD	18	nummod	6697	6699	B-persongroup-8128	_
52	18	%	%	NN	7	conj	6699	6700	I-persongroup-8128	_
52	19	in	in	IN	21	case	6701	6703	_	_
52	20	every	every	DT	21	det	6704	6709	B-persongroup-8129	_
52	21	district	district	NN	18	nmod	6710	6718	I-persongroup-8129	_
52	22	by	by	IN	23	case	6719	6721	_	_
52	23	2020	2020	CD	5	nmod	6722	6726	_	_
52	24	.	.	.	3	punct	6726	6727	_	_

53	1	While	while	IN	5	mark	6728	6733	_	_
53	2	the	the	DT	3	det	6734	6737	_	B-expressionPos-8147
53	3	GVAP	gvap	NN	5	nsubj	6738	6742	_	I-expressionPos-8147
53	4	should	should	MD	5	aux	6743	6749	_	I-expressionPos-8147
53	5	accelerate	accelerate	VB	15	advcl	6750	6760	_	I-expressionPos-8147
53	6	control	control	NN	5	dobj	6761	6768	_	I-expressionPos-8147
53	7	of	of	IN	10	case	6769	6771	_	I-expressionPos-8147
53	8	all	all	DT	10	det	6772	6775	_	I-expressionPos-8147
53	9	vaccine-preventable	vaccine-preventable	JJ	10	amod	6776	6795	_	I-expressionPos-8147
53	10	diseases	disease	NNS	6	nmod	6796	6804	_	I-expressionPos-8147
53	11	,	,	,	15	punct	6804	6805	_	I-expressionPos-8147
53	12	polio	polio	NNP	13	compound	6806	6811	_	_
53	13	eradication	eradication	NN	15	nsubjpass	6812	6823	_	_
53	14	is	be	VBZ	15	auxpass	6824	6826	_	_
53	15	set	set	VBN	0	ROOT	6827	6830	_	_
53	16	as	as	IN	19	case	6831	6833	_	_
53	17	the	the	DT	19	det	6834	6837	_	_
53	18	first	first	JJ	19	amod	6838	6843	_	_
53	19	milestone	milestone	NN	15	nmod	6844	6853	_	_
53	20	.	.	.	15	punct	6853	6854	_	_

54	1	It	it	PRP	3	nsubj	6855	6857	_	_
54	2	also	also	RB	3	advmod	6858	6862	_	_
54	3	aims	aim	VBZ	0	ROOT	6863	6867	_	_
54	4	to	to	TO	5	mark	6868	6870	_	_
54	5	spur	spur	VB	3	xcomp	6871	6875	_	_
54	6	research	research	NN	5	dobj	6876	6884	_	_
54	7	and	and	CC	6	cc	6885	6888	_	_
54	8	development	development	NN	6	conj	6889	6900	_	_
54	9	for	for	IN	12	case	6901	6904	_	_
54	10	the	the	DT	12	det	6905	6908	B-persongroup-8130	_
54	11	next	next	JJ	12	amod	6909	6913	I-persongroup-8130	_
54	12	generation	generation	NN	5	nmod	6914	6924	I-persongroup-8130	_
54	13	of	of	IN	14	case	6925	6927	_	_
54	14	vaccines	vaccine	NNS	12	nmod	6928	6936	_	_
54	15	.	.	.	3	punct	6936	6937	_	_

55	1	WHO	who	WP	3	nsubj	6949	6952	B-persongroup-8131	_
55	2	is	be	VBZ	3	aux	6953	6955	_	_
55	3	leading	lead	VBG	0	ROOT	6956	6963	_	_
55	4	efforts	effort	NNS	3	dobj	6964	6971	_	_
55	5	to	to	TO	6	mark	6972	6974	_	_
55	6	support	support	VB	3	advcl	6975	6982	_	_
55	7	regions	region	NNS	6	dobj	6983	6990	B-persongroup-8132	_
55	8	and	and	CC	7	cc	6991	6994	_	_
55	9	countries	country	NNS	7	conj	6995	7004	B-persongroup-8133	_
55	10	as	as	IN	12	mark	7005	7007	_	_
55	11	they	they	PRP	12	nsubj	7008	7012	B-persongroup-8134	_
55	12	adapt	adapt	VBP	6	advcl	7013	7018	_	_
55	13	the	the	DT	14	det	7019	7022	_	_
55	14	GVAP	gvap	NN	12	dobj	7023	7027	_	_
55	15	for	for	IN	16	case	7028	7031	_	_
55	16	implementation	implementation	NN	14	nmod	7032	7046	_	_
55	17	.	.	.	3	punct	7046	7047	_	_

56	1	In	in	IN	2	case	7048	7050	_	_
56	2	April	April	NNP	0	ROOT	7051	7056	_	_
56	3	2016	2016	CD	2	nummod	7057	7061	_	_
56	4	,	,	,	2	punct	7061	7062	_	_
56	5	WHO	who	WP	6	nsubj	7063	7066	B-persongroup-8135	_
56	6	warned	warn	VBD	2	acl:relcl	7067	7073	_	_
56	7	that	that	IN	16	mark	7074	7078	_	_
56	8	5	5	CD	16	nsubj	7079	7080	B-persongroup-8136	_
56	9	out	out	IN	14	advmod	7081	7084	I-persongroup-8136	_
56	10	of	of	IN	14	case	7085	7087	I-persongroup-8136	_
56	11	the	the	DT	14	det	7088	7091	I-persongroup-8136	_
56	12	6	6	CD	14	nummod	7092	7093	I-persongroup-8136	_
56	13	GVAP	gvap	NN	14	compound	7094	7098	I-persongroup-8136	_
56	14	targets	target	NNS	8	nmod	7099	7106	I-persongroup-8136	_
56	15	were	be	VBD	16	cop	7107	7111	_	_
56	16	off-track	off-track	JJ	6	ccomp	7112	7121	_	_
56	17	,	,	,	16	punct	7121	7122	_	_
56	18	with	with	IN	21	case	7123	7127	_	_
56	19	only	only	RB	21	advmod	7128	7132	_	_
56	20	1	1	CD	21	nummod	7133	7134	B-persongroup-8137	_
56	21	target	target	NN	16	nmod	7135	7141	I-persongroup-8137	_
56	22	on	on	IN	24	case	7142	7144	_	_
56	23	the	the	DT	24	det	7145	7148	_	_
56	24	introduction	introduction	NN	21	nmod	7149	7161	_	_
56	25	of	of	IN	27	case	7162	7164	_	_
56	26	underutilized	underutilize	VBN	27	amod	7165	7178	_	_
56	27	vaccines	vaccine	NNS	24	nmod	7179	7187	_	_
56	28	showing	show	VBG	27	acl	7188	7195	_	_
56	29	sufficient	sufficient	JJ	30	amod	7196	7206	_	_
56	30	progress	progress	NN	28	dobj	7207	7215	_	_
56	31	.	.	.	2	punct	7215	7216	_	_

57	1	This	this	DT	2	det	7217	7221	_	_
57	2	finding	finding	NN	4	nsubjpass	7222	7229	_	_
57	3	was	be	VBD	4	auxpass	7230	7233	_	_
57	4	based	base	VBN	0	ROOT	7234	7239	_	_
57	5	on	on	IN	9	case	7240	7242	_	_
57	6	the	the	DT	9	det	7243	7246	_	_
57	7	independent	independent	JJ	9	amod	7247	7258	_	_
57	8	assessment	assessment	NN	9	compound	7259	7269	_	_
57	9	report	report	NN	4	nmod	7270	7276	_	_
57	10	by	by	IN	11	case	7277	7279	_	_
57	11	SAGE	sage	NN	4	nmod	7280	7284	B-persongroup-8138	_
57	12	.	.	.	4	punct	7284	7285	I-persongroup-8138	_

58	1	The	the	DT	2	det	7297	7300	_	_
58	2	GVAP	gvap	NN	3	nsubj	7301	7305	_	_
58	3	recommends	recommend	VBZ	0	ROOT	7306	7316	_	_
58	4	3	3	CD	6	nummod	7317	7318	_	_
58	5	key	key	JJ	6	amod	7319	7322	_	_
58	6	steps	step	NNS	3	dobj	7323	7328	_	_
58	7	for	for	IN	8	mark	7329	7332	_	_
58	8	closing	close	VBG	3	advcl	7333	7340	_	_
58	9	the	the	DT	11	det	7341	7344	_	_
58	10	immunization	immunization	NN	11	compound	7345	7357	_	_
58	11	gap	gap	NN	8	dobj	7358	7361	_	_
58	12	:	:	:	11	punct	7361	7362	_	_
58	13	integrating	integrate	VBG	11	dep	7363	7374	_	_
58	14	immunization	immunization	NN	13	dobj	7375	7387	_	_
58	15	with	with	IN	18	case	7388	7392	_	_
58	16	other	other	JJ	18	amod	7393	7398	_	_
58	17	health	health	NN	18	compound	7399	7405	_	_
58	18	services	service	NNS	13	nmod	7406	7414	_	_
58	19	,	,	,	18	punct	7414	7415	_	_
58	20	such	such	JJ	23	case	7416	7420	_	_
58	21	as	as	IN	20	mwe	7421	7423	_	_
58	22	postnatal	postnatal	JJ	23	amod	7424	7433	_	_
58	23	care	care	NN	18	nmod	7434	7438	_	_
58	24	for	for	IN	25	case	7439	7442	_	_
58	25	mothers	mother	NNS	23	nmod	7443	7450	B-persongroup-8139	_
58	26	and	and	CC	25	cc	7451	7454	_	_
58	27	babies	baby	NNS	25	conj	7455	7461	B-persongroup-8140	_
58	28	;	;	:	13	punct	7461	7462	I-persongroup-8140	_
58	29	ensuring	ensure	VBG	13	parataxis	7463	7471	_	_
58	30	that	that	IN	33	mark	7472	7476	_	_
58	31	everyone	everyone	NN	33	nsubj	7477	7485	B-persongroup-8141	_
58	32	can	can	MD	33	aux	7486	7489	_	_
58	33	access	access	VB	29	ccomp	7490	7496	_	_
58	34	vaccines	vaccine	NNS	33	dobj	7497	7505	_	_
58	35	and	and	CC	33	cc	7506	7509	_	_
58	36	afford	afford	VB	33	conj	7510	7516	_	_
58	37	to	to	TO	38	mark	7517	7519	_	_
58	38	pay	pay	VB	36	xcomp	7520	7523	_	_
58	39	for	for	IN	40	case	7524	7527	_	_
58	40	them	they	PRP	38	nmod	7528	7532	_	_
58	41	.	.	.	3	punct	7532	7533	_	_

59	1	The	the	DT	3	det	7544	7547	_	_
59	2	last	last	JJ	3	amod	7548	7552	_	_
59	3	week	week	NN	9	nsubjpass	7553	7557	_	_
59	4	of	of	IN	5	case	7558	7560	_	_
59	5	April	April	NNP	3	nmod	7561	7566	_	_
59	6	each	each	DT	7	det	7567	7571	_	_
59	7	year	year	NN	5	dep	7572	7576	_	_
59	8	is	be	VBZ	9	auxpass	7577	7579	_	_
59	9	marked	mark	VBN	0	ROOT	7580	7586	_	_
59	10	by	by	IN	11	case	7587	7589	_	_
59	11	WHO	who	WP	9	nmod	7590	7593	B-persongroup-8142	_
59	12	and	and	CC	9	cc	7594	7597	_	_
59	13	partners	partner	NNS	9	conj	7598	7606	B-persongroup-8143	_
59	14	as	as	IN	17	case	7607	7609	_	_
59	15	World	World	NNP	17	compound	7610	7615	_	_
59	16	Immunization	Immunization	NNP	17	compound	7616	7628	_	_
59	17	Week	Week	NNP	13	nmod	7629	7633	_	_
59	18	.	.	.	9	punct	7633	7634	_	_

60	1	It	it	PRP	2	nsubj	7635	7637	_	_
60	2	aims	aim	VBZ	0	ROOT	7638	7642	_	_
60	3	to	to	TO	4	mark	7643	7645	_	_
60	4	accelerate	accelerate	VB	2	xcomp	7646	7656	_	_
60	5	action	action	NN	4	dobj	7657	7663	_	_
60	6	to	to	TO	7	mark	7664	7666	_	_
60	7	increase	increase	VB	4	advcl	7667	7675	_	_
60	8	awareness	awareness	NN	7	dobj	7677	7686	_	_
60	9	and	and	CC	8	cc	7687	7690	_	_
60	10	demand	demand	NN	8	conj	7691	7697	_	_
60	11	for	for	IN	12	case	7698	7701	_	_
60	12	immunization	immunization	NN	7	nmod	7702	7714	_	_
60	13	and	and	CC	7	cc	7715	7718	_	_
60	14	improve	improve	VB	7	conj	7719	7726	_	_
60	15	vaccination	vaccination	NN	17	compound	7727	7738	_	_
60	16	delivery	delivery	NN	17	compound	7739	7747	_	_
60	17	services	service	NNS	14	dobj	7748	7756	_	_
60	18	so	so	IN	24	mark	7757	7759	_	_
60	19	that	that	IN	18	mwe	7760	7764	_	_
60	20	people	people	NNS	24	nsubjpass	7766	7772	B-persongroup-8144	_
60	21	everywhere	everywhere	RB	24	advmod	7773	7783	I-persongroup-8144	_
60	22	can	can	MD	24	aux	7784	7787	_	_
60	23	be	be	VB	24	auxpass	7788	7790	_	_
60	24	protected	protect	VBN	14	advcl	7791	7800	_	_
60	25	against	against	IN	27	case	7801	7808	_	_
60	26	deadly	deadly	JJ	27	amod	7809	7815	_	_
60	27	diseases	disease	NNS	24	nmod	7816	7824	_	_
60	28	.	.	.	2	punct	7824	7825	_	_

61	1	In	in	IN	2	case	7836	7838	_	_
61	2	2016	2016	CD	17	nmod	7839	7843	_	_
61	3	,	,	,	17	punct	7843	7844	_	_
61	4	under	under	IN	7	case	7845	7850	_	_
61	5	the	the	DT	7	det	7851	7854	_	_
61	6	global	global	JJ	7	amod	7855	7861	_	_
61	7	slogan	slogan	NN	17	nmod	7862	7868	_	_
61	8	\"	\"	''	_	punct	7869	7870	_	_
61	9	Close	close	VB	7	dep	7870	7875	_	_
61	10	the	the	DT	13	det	7876	7879	_	_
61	11	immunization	immunization	NN	13	compound	7880	7892	_	_
61	12	gap	gap	NN	13	compound	7893	7896	_	_
61	13	”	”	NN	9	dobj	7896	7897	_	_
61	14	,	,	,	17	punct	7897	7898	_	_
61	15	the	the	DT	16	det	7899	7902	_	_
61	16	campaign	campaign	NN	17	nsubj	7903	7911	_	_
61	17	focused	focus	VBD	0	ROOT	7912	7919	_	_
61	18	on	on	IN	19	case	7920	7922	_	_
61	19	immunization	immunization	NN	17	nmod	7923	7935	_	_
61	20	for	for	IN	21	case	7936	7939	_	_
61	21	all	all	DT	17	nmod	7940	7943	B-persongroup-8145	_
61	22	throughout	throughout	IN	23	case	7944	7954	_	_
61	23	life	life	NN	21	nmod	7955	7959	_	_
61	24	.	.	.	17	punct	7959	7960	_	_

62	1	.	.	.	0	ROOT	7961	7962	_	_

63	1	More	more	JJR	3	advmod	7962	7966	B-persongroup-8146	_
63	2	than	than	IN	1	mwe	7967	7971	I-persongroup-8146	_
63	3	180	180	CD	4	nummod	7972	7975	I-persongroup-8146	_
63	4	countries	country	NNS	9	nsubj	7976	7985	I-persongroup-8146	_
63	5	,	,	,	4	punct	7985	7986	I-persongroup-8146	_
63	6	territories	territory	NNS	4	conj	7987	7998	I-persongroup-8146	_
63	7	and	and	CC	4	cc	7999	8002	I-persongroup-8146	_
63	8	areas	area	NNS	4	conj	8003	8008	I-persongroup-8146	_
63	9	marked	mark	VBD	0	ROOT	8009	8015	_	_
63	10	the	the	DT	11	det	8016	8019	_	_
63	11	week	week	NN	9	nmod:tmod	8020	8024	_	_
63	12	with	with	IN	13	case	8025	8029	_	_
63	13	activities	activity	NNS	9	nmod	8030	8040	_	_
63	14	including	include	VBG	16	case	8041	8050	_	_
63	15	vaccination	vaccination	NN	16	compound	8051	8062	_	_
63	16	campaigns	campaign	NNS	13	nmod	8063	8072	_	_
63	17	,	,	,	16	punct	8072	8073	_	_
63	18	training	training	NN	19	compound	8074	8082	_	_
63	19	workshops	workshop	NNS	16	conj	8083	8092	_	_
63	20	,	,	,	16	punct	8092	8093	_	_
63	21	round-table	round-table	JJ	22	amod	8094	8105	_	_
63	22	discussions	discussion	NNS	16	conj	8106	8117	_	_
63	23	and	and	CC	16	cc	8118	8121	_	_
63	24	public	public	JJ	26	amod	8122	8128	_	_
63	25	information	information	NN	26	compound	8129	8140	_	_
63	26	campaigns	campaign	NNS	16	conj	8141	8150	_	_
63	27	.	.	.	9	punct	8150	8151	_	_
